Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3036432	ex-tbvi	— (—)	1773	6759	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Asthma, hospital admission 2, infections

522

806

6.42

311.45

4.6

3.6

—

Asthma-related infections

522

806

6.42

311.45

4.6

3.6

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

615

992

5.63

309.53

4.2

3.5

—

Bronchiectasis

255

29.09

307.65

7.0

2.6

—

Asthma (only as main-diagnosis)

563

139

23.71

307.65

4.4

2.6

—

Asthma

552

139

21.03

307.65

4.3

2.6

—

Early onset COPD, excluding more controls

215

32.26

307.65

4.3

2.6

—

Asthma (only as main-diagnosis), excluding more controls

542

120

26.12

307.65

4.4

2.7

—

Influenza and pneumonia

723

736

6.30

307.65

4.4

3.3

—

Other chronic obstructive pulmonary disease

460

453

8.53

307.65

3.8

2.9

—

Asthma/COPD (KELA code 203)

652

679

6.64

307.65

4.5

2.8

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

732

770

6.55

307.65

4.3

3.4

—

Chronic lower respiratory diseases

847

680

6.69

307.65

4.4

3.0

—

Asthma, excluding more controls

531

120

23.31

307.65

4.3

2.7

—

Asthma (mode)

486

141

18.62

307.65

4.1

2.7

—

Abnormal findings on diagnostic imaging of lung

560

807

6.78

307.65

4.3

3.4

—

All pneumoniae

745

748

6.72

307.65

4.3

3.4

—

Oral corticosteroids

807

802

6.03

307.65

4.1

3.4

—

COPD (mode)

341

30.73

307.65

3.7

2.5

—

Pneumonia, organism unspecified

735

716

7.28

307.65

4.3

3.3

—

Pneumonias (Asthma/COPD co-morbidities)

757

734

6.99

307.65

4.6

3.0

—

Asthma, unspecified (mode)

437

134

24.87

307.65

4.1

2.7

—

COPD

477

465

8.54

307.65

3.8

2.9

—

Asthma, unspecified (mode), excluding more controls

419

118

26.90

307.65

4.1

2.7

—

679

527

7.88

307.65

4.7

3.0

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

679

527

7.88

307.65

4.7

3.0

—

Asthma (diagnoses ohter than nonallergic)

649

1080

5.03

282.26

4.3

3.4

—

ILD medications: prednisolone, methylprednisolone, prednisone

708

745

5.36

278.01

4.0

3.5

—

Asthma-related pneumonia

411

574

7.28

276.97

4.9

3.6

—

Asthma-related pneumonia or sepsis

411

574

7.28

276.95

4.9

3.6

—

Asthma, hospital admissions 3, pneumonia

411

574

7.28

276.95

4.9

3.6

—

ILD, hospital admission 2, with pulmonary infections

208

103

21.18

274.83

4.2

3.0

—

Inflammatory bowel disease treatment related agents

729

808

5.08

271.83

4.1

3.5

—

Later onset COPD, excluding more controls

223

25.52

264.35

3.4

2.6

—

ILD, hospital admissions 3, with pneumonia sepsis

192

22.24

258.63

4.4

2.9

—

Haemorrhage from respiratory passages

357

398

8.22

255.50

4.2

3.2

—

Other pulmonary diagnosis

373

141

13.33

252.78

4.1

2.7

—

Asthma and opportunity respiratory infection

163

32.00

248.38

7.2

3.6

—

ILD medications

685

748

5.00

247.56

3.9

3.5

—

COPD differential diagnosis

366

141

13.08

245.99

4.1

2.7

—

ILD differential diagnosis

366

141

13.08

245.98

4.1

2.7

—

Excluding asthma or asthma-COPD overlap

365

141

13.05

245.02

4.1

2.7

—

Asthma, hospital admissions , main diagnosis only

583

1086

4.78

244.45

4.4

3.5

—

363

512

7.12

240.17

4.9

3.5

—

Undetermined asthma, excluding more controls

135

47.50

231.12

4.6

2.4

—

Other diseases of pleura

472

769

5.47

228.60

3.7

3.8

—

Other chronic obstructive pulmonary disease, including avohilmo

508

829

5.14

225.13

4.0

3.6

—

Non-allergic asthma (mode), excluding more controls

151

27.58

221.16

5.1

2.5

—

Undetermined asthma

135

38.26

219.40

4.6

2.5

—

First line medication for Crohn's disease

632

716

4.80

218.83

4.0

3.5

—

COPD, hospital admissions

467

750

5.35

217.94

3.8

3.7

—

Respiratory insufficiency

130

41.94

215.44

3.8

2.5

—

COPD, early/later onset

466

753

5.30

215.05

3.8

3.7

—

Non-allergic asthma (mode)

151

25.28

214.47

5.1

2.5

—

Other interstitial pulmonary diseases

259

293

9.16

209.75

4.0

3.6

—

Cough

314

412

7.30

208.30

3.9

3.3

—

Interstitial lung disease

259

297

9.04

207.54

4.0

3.6

—

Interstitial lung disease endpoints

259

297

9.04

207.54

4.0

3.6

—

ILD, hospital admissions

256

294

9.03

204.92

4.0

3.5

—

Other respiratory diseases principally affecting the interstitium

277

355

8.05

202.50

3.9

3.7

—

Abnormalities of breathing

509

565

5.27

200.59

4.1

3.3

—

COPD, hospital admission 2, with asthma infections

375

539

6.08

200.43

4.1

3.6

—

Asthma, including avohilmo

708

1017

3.94

197.97

4.2

3.5

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

211

16.29

197.86

4.1

3.6

—

COPD/asthma/ILD related infections

539

527

5.15

193.39

4.4

3.0

—

COPD/asthma related infections

539

527

5.15

193.39

4.4

3.0

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

339

459

6.45

191.15

4.2

3.6

—

Dyspnoea

587

1117

3.91

180.51

3.9

3.7

—

COPD related to multimorbidity

394

663

5.10

174.56

3.8

—

ILD, hospital admissions 1, main diag only

226

272

8.61

174.31

4.0

3.6

—

Lung cancer and mesothelioma

149

19.05

171.09

2.8

2.5

—

COPD, hospital admissions 1, only main diagnosis

372

622

5.21

169.48

4.1

3.6

—

Obesity related asthma

270

442

6.19

156.85

4.4

3.6

—

Diseases of the respiratory system

257

134

9.66

148.47

4.5

2.9

—

Infection due to other mycobacteria

66.68

146.42

13.7

3.0

—

Other acute lower respiratory infections

387

881

4.23

143.05

4.6

3.5

—

Acute bronchitis

328

698

4.66

138.28

4.6

3.5

—

ILD medications: immunosuppressive drugs

311

625

4.65

129.16

4.0

3.6

—

Persons encountering health services in other circumstances, wide

607

959

3.28

127.84

3.9

3.7

—

577

895

3.35

125.70

4.5

3.2

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

574

947

3.31

125.43

4.0

3.7

—

Early onset COPD

215

358

6.11

123.05

4.3

3.7

—

Fever of other and unknown origin

350

762

4.12

122.82

4.2

3.7

—

Other respiratory disorders and diseases

230

419

5.60

119.88

4.1

3.8

—

Other diseases of the respiratory system

230

419

5.60

119.88

4.1

3.8

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

526

1166

3.13

114.18

4.0

3.7

—

Symptoms and signs involving the circulatory and respiratory systems

430

565

3.83

111.29

4.2

3.3

—

Bacterial pneumoniae

245

432

5.04

109.74

4.5

3.0

—

Persons encountering health services in other circumstances

245

517

4.75

106.79

3.3

3.8

—

23.98

105.81

7.3

3.6

—

Bronchitis

545

1170

2.95

104.28

4.6

3.5

—

Emphysema

103

11.55

98.81

4.2

3.0

—

Bleeding

473

1119

3.03

98.07

4.1

3.7

—

Chronic sinusitis

259

631

4.14

94.70

5.1

3.6

—

Other bacterial diseases

487

1121

2.94

94.43

5.0

3.3

—

Later onset COPD

257

486

4.28

90.86

3.4

3.6

—

Asthma mixed form (mode), excluding more controls

53.08

90.72

4.1

2.5

—

Asthma mixed form (mode)

48.26

88.96

4.1

2.8

—

Heart failure, not strict

412

910

3.09

87.55

3.5

3.9

—

Bacterial pneumonia (organism specified)

288

722

3.65

85.91

4.4

3.3

—

Pleural effusion

157

274

5.84

85.78

3.4

3.7

—

Other bacterial diseases

478

1084

2.81

84.51

4.8

3.3

—

Implicit Sepsis

409

1048

2.96

83.27

3.8

—

Simple and mucopurulent chronic bronchitis

16.03

82.32

5.7

2.7

—

Heart failure,strict

334

721

3.30

79.37

3.3

4.0

—

Unspecified chronic bronchitis

18.71

78.80

4.6

2.6

—

Bacterial pneumonia, not elsewhere classified

205

412

4.41

78.60

4.7

3.0

—

COPD-related respiratory insufficiency

130

206

6.45

78.42

3.7

—

Implicit Sepsis

415

1076

2.83

77.60

3.8

3.9

—

All influenza

139

244

5.75

75.28

5.4

2.9

—

Presence of other functional implants

354

816

3.03

73.21

4.0

3.7

—

Viral pneumonia

121

8.13

72.46

4.7

2.9

—

Allergic asthma (mode), excluding more controls

13.72

71.39

4.0

2.8

—

Heart failure, strict

362

896

2.87

68.54

3.4

3.9

—

All-cause Heart Failure

357

888

2.86

67.14

3.4

3.9

—

Bacterial Sepsis

289

795

3.13

66.97

3.6

3.7

—

Allergic asthma (mode)

11.98

65.84

4.0

2.8

—

Atypical mycobacterium lung infection

93.65

65.29

14.9

5.4

—

Morphin

21.68

64.94

4.3

3.3

—

Pain in throat and chest

297

559

3.20

64.42

3.7

3.3

—

Condition for Implicit Sepsis (Organ dysfunction codes)

397

1047

2.62

63.49

3.8

3.9

—

Idiopathic pulmonary fibrosis

151

6.74

62.11

4.1

3.5

—

Implicit bacterial Sepsis

275

780

3.07

61.82

3.6

3.8

—

Implicit viral Sepsis

192

521

3.72

60.68

4.1

3.8

—

Condition for Implicit Sepsis (Organ dysfunction codes)

388

1076

2.56

59.26

3.8

3.9

—

Other medical care

270

817

2.99

58.83

3.7

4.0

—

Diagnoses used for exclusion with ILD

189

521

3.67

58.46

4.2

3.7

—

Implicit viral Sepsis

148

342

4.38

58.41

4.1

—

Viral Sepsis

148

342

4.38

58.41

4.1

—

Pneumonia due to other infectious organisms, not elsewhere classified

16.38

57.44

4.2

3.4

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

403

1057

2.49

57.25

3.9

3.7

—

Implicit bacterial Sepsis

251

740

3.03

55.65

3.6

3.8

—

Tramadol

344

804

2.64

53.93

3.6

3.8

—

General symptoms and signs

416

847

2.47

53.69

4.0

3.8

—

Heart failure and antihypertensive medication

150

226

4.38

51.29

3.2

3.7

—

Other symptoms and signs involving the nervous and musculoskeletal systems

220

728

3.04

50.71

3.9

—

Vocal cord dysfunction

7.20

50.36

5.0

3.2

—

Explicit Sepsis

242

787

2.89

50.12

3.5

3.9

—

Acute sinusitis

219

667

3.05

50.02

5.0

3.6

—

Pleural plaque

189

5.35

49.31

3.7

3.6

—

Infections, IBD-co-morbidities

109

6.28

49.03

5.9

3.8

—

Septicaemia

235

773

2.86

47.88

3.4

3.3

—

Certain infectious and parasitic diseases

365

740

2.48

47.56

4.3

3.2

—

Other heart diseases, wide

327

797

2.52

46.77

3.6

4.2

—

Sleep apnoea

403

1155

2.27

46.66

4.1

3.8

—

Persons encountering health services for specific procedures and health care

421

1129

2.24

46.62

3.4

4.0

—

ILD-related respiratory insufficiency

10.83

45.76

4.2

4.0

—

Heart failure and bmi 25plus

193

403

3.26

44.79

3.2

3.8

—

Oxycodone

208

640

2.96

44.68

3.5

3.8

—

Bacterial infection, other or unspecified

279

937

2.53

43.80

3.7

3.3

—

Certain disorders involving the immune mechanism

123

309

4.02

43.57

5.1

3.9

—

Persons with potential health hazards related to communicable diseases

145

405

3.57

43.33

3.7

4.0

—

Pneumocystosis

16.28

42.87

4.3

4.9

—

Heart failure and coronary heart disease

251

663

2.70

42.83

3.3

3.6

—

Adrenocortical insufficiency

12.34

42.06

6.3

4.2

—

Immunodeficiencies

10.95

41.84

5.7

4.2

—

Suppurative and necrotic conditions of lower respiratory tract

101

6.71

41.35

4.1

3.8

—

Sleep apnoea, including avohilmo

405

1172

2.15

40.82

4.1

3.8

—

Covid-19 confirmed case

204

734

2.80

40.55

3.7

3.8

—

General examination and investigation of persons without complaint and reported diagnosis

294

610

2.52

40.40

3.6

—

Pneumonia due to Streptococcus pneumoniae

11.97

40.39

3.2

3.3

—

Polyarthropathies

297

801

2.43

40.36

3.7

3.8

—

Liquid cancers, helper endpoint

204

631

2.84

40.36

3.5

4.1

—

Renal tubulo-interstitial diseases

361

1231

2.19

40.00

3.7

3.8

—

Symptoms and signs involving the nervous and musculoskeletal systems

267

1103

2.43

39.97

3.9

—

ILD medications: azathioprine

114

6.10

39.94

4.6

4.3

—

Implicit fungal Sepsis

6.87

39.92

5.4

4.2

—

Bacterial infection, other or unspecified

258

899

2.50

39.90

3.6

3.3

—

Ischemic heart diseases

341

900

2.28

39.49

3.8

3.9

—

Codeine

343

812

2.30

39.35

3.7

3.8

—

L04AX Other immunosuppressants

240

951

2.53

39.31

4.2

3.8

—

FESS (DNB20)

166

5.06

39.19

5.4

4.0

—

Coronary revascularization (ANGIO or CABG)

332

888

2.30

39.19

3.9

—

Acute upper respiratory infections of multiple and unspecified sites

285

883

2.40

38.95

4.5

3.5

—

Second line medication for Crohn's disease

242

967

2.51

38.94

4.2

3.9

—

Percutaneous Coronary Intervention

331

888

2.29

38.93

3.9

—

Malaise and fatigue

223

674

2.67

38.80

3.6

3.7

—

Contact with and exposure to communicable diseases

108

268

4.03

38.58

4.0

—

L04AA Selective immunosuppressants

124

343

3.65

38.32

3.8

—

Tuberculosis

116

5.99

38.26

6.7

3.4

—

Acute upper respiratory infections

414

1234

2.07

38.17

4.4

3.6

—

Atrial fibrillation and flutter with reimbursement

126

203

3.97

38.03

3.8

3.9

—

Other heart diseases

158

310

3.34

37.90

3.7

4.3

—

Other disorders of adrenal gland

9.78

37.80

6.1

4.1

—

All kidney diseases

374

1208

2.12

37.57

3.9

3.8

—

Aplastic and other anaemias

253

974

2.44

37.48

3.7

—

Ethmoidectomy

174

4.83

37.11

5.4

4.0

—

Other septicaemia

201

720

2.70

37.11

3.5

3.3

—

Azathioprine

125

5.56

36.33

4.6

4.2

—

Malignant neoplasm of bronchus and lung, including Hilmo

147

383

3.24

36.14

2.9

4.1

—

Opioids

348

821

2.21

35.87

3.5

4.0

—

Atrial fibrillation and flutter

132

236

3.65

35.84

3.7

4.1

—

Major coronary heart disease event

347

972

2.16

35.44

3.8

—

Other pleural conditions

166

4.83

35.28

3.3

3.7

—

Osteoporosis

153

472

3.05

35.10

4.1

3.8

—

Other disorders of fluid, electrolyte and acid-base balance

178

610

2.80

35.09

3.8

3.9

—

Cardiac arrhythmias

200

473

2.76

34.88

3.8

3.9

—

Anaemias

5.73

34.78

4.3

4.7

—

Protozoal diseases

9.85

34.32

4.1

—

Lung diseases due to external agents

110

303

3.68

34.32

3.6

3.7

—

Sleep disorders (combined)

425

1119

2.00

34.20

4.0

3.7

—

Provisional assignment of new diseases of uncertain etiology

235

985

2.39

34.07

3.7

3.8

—

All chronic kidney diseases

252

879

2.35

33.83

3.5

3.8

—

Other anaemias

233

926

2.41

33.81

3.5

3.7

—

Codes for special purposes

235

989

2.38

33.76

3.7

3.8

—

Non-ischemic cardiomyopathy

169

476

2.88

33.70

3.6

3.8

—

Other and unspecified anaemias

231

922

2.40

33.41

3.5

3.7

—

Renal failure

249

947

2.34

33.39

3.6

3.7

—

Emergency coronary revascularization (for ACS)

353

1032

2.09

33.09

3.9

3.8

—

Any reimbursement code in KELA

135

187

3.63

33.08

4.6

3.5

—

Fungal Sepsis

8.20

32.95

5.9

4.3

—

Reimbursement for rheumatic diseases

238

1017

2.34

32.84

3.9

—

Hard cardiovascular diseases

321

892

2.15

32.42

3.9

3.8

—

Osteopathies and chondropathies

242

981

2.31

31.92

3.8

3.9

—

Malignant neoplasm of respiratory system and intrathoracic organs

138

372

3.12

31.80

2.9

4.1

—

Implicit fungal Sepsis

8.41

31.33

5.7

4.4

—

Constipation

364

1270

1.99

31.03

4.0

3.7

—

Parasetamol

241

507

2.41

30.19

3.8

4.1

—

Certain infectious and parasitic diseases

264

573

2.31

30.08

4.4

3.1

—

Autoimmune diseases related-to ILD

298

1234

2.07

29.67

3.9

3.8

—

Other diseases of upper respiratory tract

407

1105

1.92

29.51

4.4

3.5

—

Pulmonary heart disease, diseases of pulmonary circulation

172

670

2.58

29.41

3.8

3.6

—

Non-small cell lung cancer, including Hilmo

108

305

3.37

29.22

3.0

4.3

—

Pain, not elsewhere classified

118

377

3.15

29.13

3.6

3.8

—

Pleural plaque with presence of asbestos

192

4.15

28.68

3.8

3.3

—

Complications of surgical and medical care, not elsewhere classified

378

1360

1.91

28.58

3.9

3.7

—

Chronic kidney disease

177

696

2.51

28.43

3.5

3.7

—

GASTRO-related operations

255

562

2.28

28.21

4.1

3.6

—

Any gastric operation

255

562

2.28

28.21

4.1

3.6

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

197

811

2.37

27.93

4.7

3.5

—

Autoimmune diseases excluding thyroid diseases, strict definition

371

1053

1.93

27.71

3.9

3.7

—

Autoimmune diseases excluding thyroid diseases

380

1084

1.92

27.65

3.9

3.7

—

Codeine or tramadol medication

411

1208

1.87

27.60

3.7

3.8

—

Spondylosis

237

878

2.21

27.54

3.6

3.7

—

Erysipelas

277

1021

2.08

27.21

3.5

3.3

—

Benzodiazepine use

374

1372

1.88

27.16

3.8

—

Other diseases of blood and blood-forming organs, wide

120

404

2.99

27.16

3.8

4.1

—

Spondylopathies

318

950

2.01

26.89

3.5

3.7

—

Disorders of other endocrine glands

177

725

2.41

26.21

4.1

3.6

—

Chronic rhinitis, nasopharyngitis and pharyngitis

124

434

2.87

26.14

4.7

3.7

—

Methotrexate

125

4.75

26.11

4.0

3.7

—

Tuberculosis, IBD comorbidity

142

4.51

25.94

6.2

3.6

—

Vasomotor and allergic rhinitis

123

423

2.86

25.76

4.5

3.7

—

Respiratory tuberculosis, confirmed and not-confirmed

5.35

25.63

7.1

3.5

—

Respiratory tuberculosis

5.35

25.63

7.1

3.5

—

Iron deficiency anaemia

196

850

2.28

25.60

3.8

3.7

—

Mycoses

133

490

2.73

25.51

4.7

3.8

—

Unspecified acute lower respiratory infection

227

3.64

25.48

5.1

3.6

—

Tuberculosis, wide

149

4.36

25.30

6.2

3.6

—

Other soft tissue disorders, not elsewhere classified

335

1021

1.93

25.27

3.4

4.0

—

Sulfasalazine

301

3.24

25.20

3.5

3.6

—

Viral pneumonia (unknown virus, not influenza)

5.84

24.93

3.6

4.4

—

Pain in limb

296

1003

1.98

24.85

3.5

3.9

—

Other disorders of white blood cells

5.80

24.64

4.4

3.8

—

Systemic connective tissue disorders

160

657

2.45

24.58

4.0

3.7

—

Suggestive for eosinophilic asthma

112

4.88

24.56

4.8

3.9

—

Malignant neoplasm of bronchus and lung

116

329

2.95

24.51

2.8

4.1

—

Exclusions for E4_PCOS_BROAD

252

3.44

24.49

4.8

4.3

—

Disorders of lens

269

822

2.05

24.42

4.1

3.7

—

Pneumothorax

103

5.02

23.95

4.5

3.6

—

DVT of lower extremities and pulmonary embolism

198

899

2.20

23.85

3.5

3.7

—

Dysphagia

123

451

2.74

23.84

3.4

3.8

—

Oedema, not elsewhere classified

135

511

2.62

23.84

3.4

3.7

—

Hypo-osmolality and hyponatraemia

103

341

3.03

23.81

3.7

3.9

—

Non-rheumatic valve diseases

183

566

2.34

23.80

3.3

4.1

—

Valvular heart disease excluding rheumatic fever

183

567

2.34

23.74

3.3

4.2

—

Pulmonary embolism

150

609

2.48

23.64

3.6

3.7

—

Hypertension, essential

263

725

2.06

23.61

4.1

3.9

—

Abnormalities of heart beat

110

374

2.89

23.51

3.3

—

Enlarged lymph nodes

221

3.55

23.43

3.7

4.1

—

Headache

197

712

2.21

23.10

3.8

—

Pyothorax

5.71

23.10

4.7

4.2

—

Bronchitis, not specified as acute or chronic

5.63

23.01

4.9

3.1

—

Pulmonary heart disease

150

617

2.45

22.99

3.6

3.8

—

Other antidepressants

380

1078

1.81

22.95

4.0

3.9

—

Venous thromboembolism

239

1146

2.02

22.92

3.4

3.8

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

104

3.96

22.67

5.4

3.0

—

Concussion

178

639

2.28

22.46

4.0

3.9

—

Nutritional anaemias

219

1029

2.06

22.09

3.9

3.6

—

Diseases of oesophagus, stomach and duodenum

370

1245

1.78

22.04

3.9

3.7

—

Conduction disorders

130

405

2.62

21.95

3.2

4.2

—

Other systemic involvement of connective tissue (FG)

118

436

2.69

21.94

4.0

—

Low back pain

263

966

1.96

21.88

4.3

3.9

—

L04AD Calcineurin inhibitors

136

4.23

21.83

4.2

—

Acute renal failure

121

463

2.63

21.64

3.9

3.7

—

Acute tubulo-interstitial nephritis

242

1061

1.97

21.33

3.7

3.9

—

Other arrhythmias

202

718

2.13

21.23

3.5

4.2

—

Finngen Rheumatological endpoints

317

977

1.85

21.10

3.8

—

Symptoms and signs involving the digestive system and abdomen

345

956

1.81

20.87

3.5

4.0

—

Paroxysmal tachycardia

206

3.31

20.86

4.2

4.4

—

Coronary atherosclerosis

252

810

1.97

20.85

3.3

3.7

—

Asthma and allergy, excluding more controls

16.35

20.72

5.2

2.3

—

Chronic lymphocytic leukaemia

8.86

20.72

3.3

3.7

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

8.86

20.72

3.3

3.7

—

Chronic lymphocytic leukaemia, helper endpoint

8.86

20.72

3.3

3.7

—

Problems related to lifestyle

4.98

20.62

3.1

3.9

—

Transplanted organ and tissue status

117

4.40

20.55

4.1

3.7

—

Drug-induced adrenocortical insufficiency

20.88

20.54

7.7

4.4

—

Asthma and allergy

15.58

20.35

5.2

2.3

—

Senile cataract

248

775

1.97

20.16

4.1

3.7

—

Metabolic disorders

332

1137

1.79

20.10

4.1

3.7

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

146

3.96

19.91

4.3

3.7

—

Other cataract

184

650

2.15

19.89

4.1

3.7

—

Rheumatoid arthritis

140

531

2.38

19.82

4.2

3.8

—

Biological medicines for asthma

22.33

19.62

7.8

5.7

—

Other special examinations and investigations of persons without complaint or reported diagnosis

241

611

2.00

19.61

4.0

3.6

—

Intracranial trauma

192

641

2.11

19.53

3.9

—

Ischaemic heart disease, wide definition

292

988

1.84

19.41

3.5

3.8

—

Gout

142

537

2.34

19.35

3.3

3.5

—

Episodal and paroxysmal disorders

358

1045

1.75

19.32

3.6

3.8

—

Hypertensive diseases (excluding secondary)

133

307

2.52

19.24

4.5

4.3

—

Factors influencing health status and contact with health services

102

171

3.00

19.19

4.9

3.5

—

Abdominal and pelvic pain

336

956

1.77

18.88

3.5

4.0

—

Primary_lymphoid and hematopoietic malignant neoplasms

126

526

2.41

18.83

3.4

3.8

—

Other diseases of intestines

340

1110

1.75

18.81

3.6

3.9

—

Biological medication for rheuma

185

3.48

18.73

3.4

4.7

—

Erysipelas

212

956

1.97

18.69

3.7

3.3

—

Other symptoms and signs involving the urinary system

205

3.35

18.69

3.4

3.9

—

Other symptoms and signs involving the circulatory and respiratory systems

5.61

18.66

5.6

3.7

—

Extreme obesity with alveolar hypoventilation

6.14

18.61

3.7

4.0

—

Invasive ventilation

110

4.33

18.52

2.9

3.9

—

Seropositive rheumatoid arthritis

112

445

2.52

18.44

4.3

4.0

—

Syncope and collapse

164

653

2.16

18.39

3.5

3.7

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

5.15

18.39

4.1

4.3

—

Viral infections characterized by skin and mucous membrane lesions

290

1404

1.77

18.26

4.4

3.7

—

Disorders of gallbladder, biliary tract and pancreas

354

1316

1.70

18.26

3.9

3.8

—

Other systemic involvement of connective tissue

118

485

2.45

18.24

4.0

3.8

—

Streptococcal septicaemia

134

3.92

18.03

3.3

3.5

—

Candidiasis

111

448

2.49

17.85

5.2

3.5

—

Immunodeficiency with predominantly antibody defects

14.02

17.84

5.3

4.4

—

Other and unspecified iron deficiency

141

633

2.24

17.78

4.0

3.6

—

Special screening examination for other diseases and disorders

163

3.58

17.72

4.3

3.9

—

Dorsalgia

322

989

1.75

17.68

3.8

3.9

—

Non-invasive ventilation

247

2.94

17.55

3.9

—

Unknown and unspecified causes of morbidity

4.70

17.50

3.6

3.9

—

Chronic laryngitis and laryngotracheitis

219

3.17

17.45

4.1

3.8

—

Gastro-oesophageal reflux disease

246

1163

1.83

17.36

4.1

3.7

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

200

2.95

17.34

3.6

4.0

—

Used for control exclusion in common control thyroid runs

344

1018

1.71

17.30

3.7

—

Autoimmune diseases

359

1086

1.68

17.11

3.8

3.7

—

Explicit bacterial Sepsis

172

3.46

17.10

3.6

3.8

—

Use of hypnotics and sedatives

360

1241

1.67

17.05

3.8

—

Sarcoidosis

228

3.10

16.97

5.3

4.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

242

1200

1.82

16.95

3.8

—

Any death

248

973

1.83

16.94

3.4

3.8

—

Dermatitis

220

1180

1.86

16.85

3.9

3.7

—

Other reaction to severe stress, and adjustment disorders

108

443

2.45

16.79

3.9

4.0

—

ILD medications: nintedanib

44.23

16.68

4.0

3.4

—

Substance use, excluding alcohol

257

2.93

16.62

3.7

4.4

—

Other and unspecified dermatitis

185

947

1.96

16.53

3.9

3.7

—

Aspergillosis

22.48

16.23

6.0

5.6

—

Nausea and vomiting

106

429

2.43

16.19

3.6

4.0

—

Intestinal infectious diseases

315

1427

1.68

16.16

4.1

3.8

—

Injuries to the thorax

182

934

1.95

16.14

3.7

3.8

—

Diseases of arteries, arterioles and capillaries

271

1146

1.75

16.12

3.5

3.7

—

Endocarditis

6.23

15.96

2.9

3.6

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

112

479

2.35

15.93

4.3

3.6

—

Viral infections characterized by skin and mucous membrane lesions

153

742

2.07

15.89

4.3

3.7

—

Presbycusis

322

2.67

15.88

4.7

3.6

—

Non-Hodgkin lymphoma, all, including Hilmo

232

3.00

15.86

3.2

4.5

—

Symptoms and signs involving the urinary system

279

1239

1.72

15.67

3.6

3.8

—

Abscess of lung

14.26

15.64

4.2

4.9

—

Rheumatism, unspecified

178

3.28

15.53

3.6

4.4

—

Rheumatoid arthritis, including avohilmo

153

750

2.05

15.50

4.1

3.6

—

Care involving use of rehabilitation procedures

211

1056

1.84

15.46

3.4

4.0

—

Hypertensive diseases

236

729

1.83

15.39

4.2

4.0

—

Hypertension

236

729

1.83

15.38

4.2

4.0

—

Non-small cell lung cancer

203

3.11

15.37

2.8

4.5

—

Myocardial infarction

193

708

1.92

15.34

3.4

3.7

—

Gout, FINNGEN

142

679

2.10

15.28

3.3

3.7

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

111

290

2.42

15.25

4.2

4.1

—

Cardiovascular diseases (excluding rheumatic etc)

132

337

2.26

15.14

4.0

4.2

—

Cardiodefibrillation

167

851

1.97

15.10

3.5

3.8

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

11.13

15.08

8.1

4.4

—

Fitting and adjustment of other devices

155

692

2.03

15.07

3.2

3.8

—

Other CVD (FINNGEN)

113

3.59

14.91

4.1

4.0

—

Respiratory tuberculosis, confirmed

11.63

14.87

8.3

4.5

—

Other functional intestinal disorders

173

832

1.94

14.78

3.6

3.9

—

Lower back pain or/and sciatica

345

1400

1.61

14.78

4.1

3.8

—

Major coronary heart disease event excluding revascularizations

226

834

1.81

14.77

3.6

—

AV-block

272

2.66

14.71

3.0

4.3

—

Childhood asthma (age<16)

17.24

14.70

4.9

2.3

—

Childhood asthma (age<16), excluding more controls

17.23

14.70

4.9

2.3

—

Candidiasis

190

3.13

14.62

4.4

—

Symptoms and signs concerning food and fluid intake

150

3.42

14.59

3.7

4.5

—

Other/unspecified seropositive rheumatoid arthritis

112

499

2.26

14.53

4.3

3.6

—

Diseases of the skin and subcutaneous tissue

325

988

1.65

14.50

4.0

3.6

—

Other specified/unspecified arthritis

103

445

2.32

14.35

4.3

4.0

—

Other complications of surgical and medical care, not elsewhere classified

128

3.62

14.35

5.5

4.1

—

All influenza (not pneumonia)

128

3.61

14.33

4.8

2.9

—

Disorders of mineral metabolism

110

3.85

14.30

3.7

4.5

—

Seropositive rheumatoid arthritis, wide

112

503

2.24

14.26

4.3

3.6

—

Other arthritis (FG)

114

516

2.22

14.23

4.2

4.0

—

Other diseases of urinary system

335

1166

1.62

14.13

3.8

—

Personality disorders, excluding more controls

276

2.69

14.06

3.6

4.1

—

Other general symptoms and signs

6.15

14.02

4.2

3.4

—

Lung transplant status

25.42

13.99

6.8

6.5

—

Lung transplantation

25.41

13.99

6.8

6.5

—

Presence of other devices

102

444

2.30

13.86

3.2

3.5

—

Other specified/unspecified systemic involvement of connective tissue

5.05

13.84

4.6

4.5

—

Chronic apical periodontitis

357

1287

1.58

13.81

4.0

3.8

—

Unspecified haematuria

181

804

1.87

13.77

3.6

3.8

—

Pneumonia derived septicemia

6.30

13.76

4.0

3.7

—

Allergic bronchopulmonary aspergillosis (ABPA)

+∞

13.75

6.7

0.0

—

L01XE Protein kinase inhibitors

4.20

13.69

3.6

3.7

—

Abnormal findings on examination of blood, without diagnosis

196

998

1.81

13.60

4.5

3.7

—

Complications of procedures, not elsewhere classified

267

1330

1.66

13.59

3.8

—

Iron deficiency anaemia secondary to blood loss (chronic)

299

2.59

13.56

3.4

3.7

—

Seropositive rheumatoid arthritis, strict definition

243

2.78

13.48

4.6

3.8

—

Osteoporosis with pathological fracture (FG)

3.96

13.42

3.4

4.8

—

Non-selective monoamine reuptake inhibitors

137

655

2.02

13.42

3.8

3.9

—

Abnormal results of function studies

4.15

13.20

3.7

3.9

—

Fracture of rib(s), sternum and thoracic spine

125

609

2.06

12.98

3.8

3.6

—

Malignant neoplasm, wide definition for exclusion

266

935

1.67

12.90

3.4

4.0

—

Eustachian salpingitis and obstruction

4.86

12.84

4.3

4.7

—

Other nutritional deficiencies

196

1043

1.77

12.83

3.5

4.0

—

Myocardial infarction, strict

176

676

1.86

12.77

3.5

3.7

—

Tumor necrosis factor alpha inhibitors

164

3.12

12.71

3.4

4.6

—

Intestinal infectious diseases

369

1373

1.54

12.67

4.0

3.8

—

Endocrine, nutritional and metabolic diseases

220

630

1.77

12.67

4.0

3.7

—

Gout, idiopatic and unspecified

123

602

2.05

12.65

3.4

3.7

—

Other disorders of urethra and urinary system

238

1019

1.69

12.55

3.7

3.9

—

Mental and behavioural disorders due to tobacco

116

3.56

12.53

4.4

4.2

—

Injuries to the head

349

1390

1.55

12.47

3.7

3.9

—

Pneumococcal septicemia

5.69

12.44

4.0

4.7

—

Exposure to unspecified factor

313

1434

1.57

12.44

3.8

—

Hypokalaemia

193

2.92

12.41

4.2

—

Smoking dependency

117

3.53

12.37

4.4

4.3

—

Dental operations

223

657

1.75

12.32

3.9

3.6

—

Pleural plaque without asbestos

4.03

12.23

4.1

3.5

—

Substance abuse, excluding more controls

191

927

1.76

12.04

3.3

3.8

—

Eosinophilia

13.75

12.01

5.3

5.4

—

Other bacterial intestinal infections

348

2.37

12.00

4.6

3.7

—

Fibromyalgia

3.93

11.98

4.2

5.0

—

Other disorders of ear

301

1250

1.58

11.98

4.5

3.7

—

Other disorders of bladder

243

2.65

11.86

4.0

3.9

—

Malignant neoplasm

256

921

1.65

11.84

3.5

4.0

—

Retention of urine

153

671

1.88

11.81

3.8

3.7

—

Hernia of abdominal wall, postoperative

255

2.60

11.79

3.3

3.6

—

126

3.35

11.74

5.7

4.3

—

Enterocolitis due to Clostridium difficile

205

2.80

11.72

5.5

3.6

—

Mouth breathing

137

716

1.92

11.66

4.4

3.7

—

Mycoses

264

1438

1.60

11.65

4.7

3.7

—

Adalimumab

3.84

11.62

3.7

5.5

—

Gout, unspecified

103

488

2.12

11.59

3.2

3.6

—

Respiratory tuberculosis, clinically confirmed

14.05

11.54

7.0

4.9

—

Obesity due to excess calories

142

755

1.89

11.51

3.5

4.1

—

Other diseases of pericardium

4.55

11.43

4.0

3.5

—

Cholelithiasis, broad definition with cholecystitis

293

1259

1.57

11.42

3.7

3.8

—

Diseases of the digestive system

176

998

1.76

11.38

3.8

3.7

—

Complications of medical and surgical care

246

1405

1.61

11.35

4.1

3.8

—

Viral pneumonia (known virus, not influenza)

8.45

11.33

3.9

4.1

—

Dorsopathies

305

990

1.57

11.21

3.5

3.9

—

Drug-induced osteoporosis with pathological fracture

13.05

11.21

3.3

6.5

—

Other necrotizing vasculopathies

116

3.39

11.09

4.4

4.2

—

Dental caries

370

2.24

11.06

3.8

3.6

—

Caries of dentine

320

2.35

11.06

3.9

3.5

—

Hyperlipidaemia, other/unspecified

159

815

1.80

11.01

3.5

3.7

—

Caries of dentine, including avohilmo

267

848

1.61

11.00

4.1

3.8

—

Pneumoconiosis due to asbestos and other mineral fibres

4.74

11.00

3.6

3.3

—

Gastrointestinal diseases

150

394

1.91

10.97

4.7

3.5

—

Pneumonia due to Haemophilus influenzae

30.91

10.96

7.7

6.2

—

Weight loss

174

2.90

10.95

3.8

4.1

—

Other pulmonary heart/vessel disease

3.86

10.94

4.0

3.5

—

Depression medications

3.03

10.93

3.4

4.6

—

Sequelae of external causes of morbidity and mortality

103

500

2.07

10.89

3.6

3.8

—

Diabetes, varying definitions

312

1192

1.54

10.85

4.2

3.8

—

Pacemaker

151

799

1.82

10.84

3.2

3.7

—

Conductive and sensorineural hearing loss

274

1178

1.57

10.82

4.1

3.7

—

Cystic fibrosis with pulmonary manifestations

+∞

10.80

21.6

0.0

—

Depression or dysthymia

221

729

1.68

10.80

4.0

3.7

—

Neurological diseases

252

779

1.63

10.78

3.7

3.9

—

Type 2 diabetes, wide definition

270

1096

1.58

10.77

3.4

3.8

—

Allergic rhinitis

342

2.29

10.76

4.7

3.9

—

Non-small cell lung cancer, squamous

3.81

10.76

2.9

3.7

—

Nonhereditary hypogammaglobulinemia

22.20

10.76

5.2

5.3

—

Other and unspecified disorders of white blood cells

4.60

10.73

3.7

4.3

—

GI-bleeding

137

739

1.86

10.67

3.7

3.6

—

Sequelae with surgical and medical care as external cause

400

2.19

10.60

3.0

3.8

—

Abnormal weight loss

161

2.94

10.60

3.7

4.2

—

Nonsuppurative otitis media

214

2.55

10.60

5.0

3.9

—

Adjustment and management of implanted device

362

2.25

10.57

3.0

3.9

—

Other abnormal findings of blood chemistry

4.27

10.57

5.0

3.8

—

Personality disorders

318

2.33

10.56

3.6

4.0

—

Carrier of infectious disease

9.31

10.54

3.5

5.7

—

Cerebrovascular diseases (FINNGEN)

244

2.33

10.52

3.1

4.0

—

Cholelithiasis

279

1240

1.55

10.52

3.7

3.8

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

115

3.33

10.52

5.5

3.8

—

Dermatographic urticaria

4.36

10.51

3.7

3.8

—

Other hearing loss

122

623

1.92

10.49

4.4

3.7

—

Diabetes mellitus

311

1193

1.53

10.49

4.2

3.8

—

Other/unspecified rheumatoid arthritis

224

2.61

10.43

4.9

3.9

—

Any event in cancer register

266

994

1.58

10.42

3.6

3.9

—

Bacterial intestinal infections, IBD co-morbidities

358

2.25

10.42

5.4

3.8

—

Cardiomyopathy

278

2.42

10.36

3.4

4.4

—

Secondary right heart disease

3.97

10.32

4.2

3.6

—

Polycystic ovarian syndrome, consortium definition

167

557

1.78

10.25

4.0

4.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

315

1340

1.51

10.23

3.7

3.8

—

Diarrhoea and gastroenteritis of presumed infectious origin

312

1365

1.51

10.23

3.7

3.8

—

Zoster [herpes zoster]

175

1011

1.71

10.23

4.7

3.7

—

Diseases of pulp and periapical tissues and dental caries

230

720

1.64

10.19

4.0

3.8

—

Cardiovascular diseases

109

283

2.07

10.19

4.2

4.4

—

Mixed connective tissue disease

4.12

10.15

4.6

4.3

—

Other bacterial intestinal infections

422

2.12

10.05

4.5

3.9

—

Spinal stenosis

187

844

1.69

10.01

3.6

3.7

—

Dental caries, including avohilmo

251

806

1.60

10.00

4.0

3.9

—

Pneumonitis due to solids and liquids

172

2.81

10.00

3.5

3.7

—

Agranulocytosis

172

2.81

9.99

4.1

4.2

—

Sicca syndrome [Sjögren]

104

3.39

9.99

4.1

5.0

—

5-aminosalicylic acid

183

2.74

9.98

4.7

3.9

—

Angina pectoris

193

767

1.68

9.96

3.5

3.7

—

Diseases of pulp and periapical tissues, including avohilmo

322

1111

1.50

9.91

3.6

3.8

—

Obesity and other hyperalimentation

176

1005

1.69

9.90

3.5

4.0

—

Sensorineural hearing loss

262

1148

1.55

9.85

4.1

3.7

—

Cardiac murmurs and other cardiac sounds

4.00

9.77

6.8

3.4

—

Other diseases of the digestive system

133

733

1.82

9.72

3.7

3.6

—

Other and unspecified drugs and medicaments

111

3.27

9.70

5.7

4.3

—

Solid cancers, helper endpoint

245

917

1.58

9.69

3.4

4.0

—

Mental and behavioural disorders due to psychoactive substance use

198

1127

1.63

9.66

3.3

4.0

—

Obesity

174

999

1.68

9.66

3.5

4.0

—

Gout, strict definition

436

2.08

9.64

3.5

3.6

—

Type 2 diabetes

303

1181

1.50

9.52

3.9

3.8

—

Other infectious diseases

128

3.07

9.50

4.1

3.7

—

Non-Hodgkin lymphoma, all

3.90

9.42

3.7

3.6

—

Other disorders of skin and subcutaneous tissue

232

1322

1.56

9.41

4.3

3.8

—

Dermatitis and eczema

334

1416

1.46

9.39

4.4

3.7

—

Psychiatric diseases

312

1048

1.49

9.26

3.9

3.8

—

Glomerular diseases

344

2.19

9.25

3.3

3.9

—

Hypothyroidism (congenital or acquired)

2.95

9.22

4.4

4.7

—

Neoplasms

191

607

1.67

9.21

4.4

3.8

—

Other necrotizing vasculopathies (FG)

3.40

9.18

4.8

3.9

—

Drug-induced neutropenia

100

3.33

9.16

3.4

4.7

—

Drug-induced osteoporosis

11.80

9.13

7.9

4.6

—

Substance abuse

191

1111

1.62

9.09

3.3

4.0

—

Disorders of adult personality and behaviour

328

2.20

9.02

3.8

4.1

—

Urticaria and erythema

105

550

1.91

9.02

3.8

4.0

—

Osteonecrosis

3.67

8.99

3.1

4.2

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

296

1365

1.48

8.98

3.9

3.8

—

Valvular operations

236

2.43

8.92

3.0

4.2

—

Lymphoid leukaemia

102

3.27

8.90

3.2

3.9

—

Respiratory conditions due to other external agents

8.09

8.89

3.5

5.5

—

Hypoparathyroidism

4.93

8.85

3.7

4.4

—

Other viral diseases

382

2.09

8.84

4.6

3.9

—

Injuries to the hip and thigh

174

960

1.65

8.80

3.4

3.8

—

Fall on same level

331

1245

1.45

8.79

3.9

3.8

—

Soft tissue disorders

300

1041

1.49

8.78

3.4

3.9

—

Emotionally unstable personality disorder

3.51

8.77

3.9

4.2

—

ILD medications: pirfenidone

14.51

8.76

6.1

3.0

—

Somatoform disorder

226

2.44

8.75

2.8

3.9

—

Hypothyroidism and >3 levothyroxin purchases

2.89

8.75

4.4

4.7

—

Hypothyroidism, levothyroxine purchases

2.89

8.75

4.4

4.7

—

Other and unspecified immunodeficiencies with predominantly antibody defects

14.39

8.74

5.0

5.5

—

Etanercept

4.13

8.71

3.3

5.5

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

290

1180

1.48

8.69

3.8

—

Meniscus derangement

182

749

1.64

8.66

4.2

3.7

—

Disorders of calcium metabolism

3.48

8.64

3.0

3.9

—

Secondary hypertension

3.56

8.64

3.5

4.1

—

Open wound of head

182

1091

1.61

8.56

3.7

3.9

—

Other dorsopathies, not elsewhere classified

282

989

1.49

8.53

3.5

3.9

—

Respiratory tuberculosis, not confirmed

3.54

8.53

5.7

3.6

—

Hernia

285

1296

1.48

8.53

4.1

3.8

—

Polyarthrosis

347

2.10

8.53

3.9

4.0

—

Diabetes, insulin treatment (Kela reimbursement)

311

1292

1.46

8.52

3.9

3.8

—

Non-allergic asthma

115

3.06

8.52

2.8

4.2

—

Other (seronegative) rheumatoid arthritis, wide

337

2.15

8.48

4.1

3.7

—

Paralytic ileus and intestinal obstruction

101

534

1.90

8.47

3.4

3.8

—

Cardiomyopathies, Primary/intrinsic

188

2.57

8.46

3.3

4.0

—

Care involving dialysis

121

3.00

8.45

2.8

4.0

—

Coxarthrosis [arthrosis of hip](FG)

188

823

1.61

8.41

3.4

3.7

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

169

693

1.66

8.41

3.6

3.9

—

Secondary and unspecified malignant neoplasm of lymph nodes

127

2.93

8.38

2.7

4.8

—

Acute pharyngitis

110

3.07

8.36

6.2

3.8

—

Superficial injury of lower leg

392

2.05

8.36

3.3

4.0

—

Vasomotor rhinitis (mode)

3.32

8.34

4.4

4.3

—

Budesonide

122

2.96

8.32

4.3

3.8

—

Chronic nephritic syndrome

4.12

8.27

3.2

4.5

—

Disorders of parathyroid gland

363

2.08

8.22

3.6

3.7

—

Other joint disorders

241

831

1.53

8.22

4.1

3.9

—

Ill-defined and unknown causes of mortality

203

2.48

8.21

3.0

3.6

—

STROKE

156

632

1.68

8.20

3.4

3.8

—

Anxiety disorders, excluding more controls

228

968

1.53

8.19

3.8

3.9

—

External causes of morbidity and mortality

196

611

1.61

8.17

3.9

4.0

—

Other diseases of anus and rectum

110

605

1.82

8.12

3.6

3.8

—

Cardiomyopathy (excluding other)

192

2.51

8.12

3.3

3.9

—

Other/unspecified dorsalgia

114

630

1.80

8.10

3.4

3.9

—

Other ill-defined and unspecified causes of mortality

181

2.56

8.07

2.9

3.5

—

Deforming dorsopathies

453

1.95

8.02

4.1

—

Other disorders of lacrimal gland

110

609

1.81

8.01

5.2

3.8

—

Hyperkalaemia

109

3.06

8.01

4.0

3.2

—

Other and unspecified effects of external causes

392

2.02

7.99

3.7

4.0

—

Selective serotonin reuptake inhibitors

300

1080

1.45

7.91

3.8

3.9

—

Any mental disorder

336

1184

1.42

7.88

3.8

—

Adverse effects, not elsewhere classified

269

2.24

7.88

4.0

4.3

—

Other viral diseases

487

1.90

7.87

4.5

3.8

—

Type 2 diabetes, definitions combined

289

1169

1.45

7.85

3.6

3.8

—

Other infectious diseases

150

2.68

7.72

4.0

3.7

—

Extracorporeal dialysis

101

3.10

7.71

2.9

4.0

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

100

545

1.84

7.69

4.0

3.9

—

Noninfective enteritis and colitis

138

824

1.68

7.69

4.3

3.7

—

Disorders of plasma-protein metabolism, not elsewhere classified

19.06

7.66

5.9

2.3

—

Brachial plexus disorders

3.35

7.64

3.1

4.3

—

Dermatitis due to substances taken internally

3.74

7.63

6.0

4.5

—

Insulin, fast-acting

118

677

1.75

7.63

4.9

3.7

—

Type 2 diabetes, strict (exclude DM1)

290

1181

1.44

7.62

3.6

3.8

—

Persons encountering health services for examination and investigation

193

611

1.59

7.61

4.3

3.6

—

Open wound of forearm

140

2.73

7.59

3.4

3.9

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

463

1.91

7.56

3.2

3.7

—

Volume depletion

181

2.50

7.56

3.7

3.8

—

Zoster [herpes zoster]

360

2.04

7.55

4.8

3.7

—

Intracranial injury

184

1120

1.56

7.53

3.8

3.9

—

Non-small cell lung cancer, squamous, helper endpoint

108

2.99

7.51

2.9

3.5

—

Other metabolic disorders

158

2.61

7.50

3.9

4.4

—

Glomerulonephritis

164

2.58

7.50

3.4

3.8

—

Arthropathies

245

831

1.50

7.47

3.9

—

Disorders of sclera, cornea, iris and ciliary body

162

1017

1.60

7.45

4.2

3.8

—

Cystic fibrosis with intestinal manifestations

+∞

7.45

24.6

0.0

—

Specific personality disorders

263

2.21

7.43

3.7

3.9

—

Haemorrhage, not elsewhere classified

3.57

7.43

4.2

3.8

—

Abnormal spermatozoa

296

2.14

7.42

3.4

3.5

—

Sequelae of tuberculosis

6.06

7.41

5.6

4.9

—

L04AC Interleukin inhibitors

3.75

7.35

3.3

5.1

—

Diseases of oral cavity, salivary glands and jaws

201

666

1.55

7.35

3.8

3.7

—

Rare circulating lymphoid malignancy, including Hilmo

6.88

7.30

4.0

4.8

—

Other CVD

441

1.91

7.28

4.1

3.7

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

4.15

7.27

2.6

4.5

—

Other or unspecified ileus, impaction or obstruction

372

2.00

7.26

3.4

3.8

—

Anxiety disorders

235

1109

1.48

7.23

3.8

3.9

—

Peripheral artery disease

174

884

1.57

7.23

3.4

3.8

—

Type 2 diabetes, definitions combined, including avohilmo

287

1169

1.43

7.23

3.6

3.8

—

Diseases of the ear and mastoid process

321

1144

1.41

7.23

4.5

3.6

—

Nasal polyp

339

2.04

7.23

4.3

3.8

—

Pollen allergy

136

2.69

7.22

4.1

4.6

—

Type of accident

506

1.84

7.22

4.0

3.9

—

Insulin medication

199

1104

1.52

7.19

4.2

3.7

—

Secondary uncertain malignant neoplasm

229

2.28

7.17

3.0

4.6

—

Internal derangement of knee

111

635

1.74

7.16

3.8

3.9

—

Intestinal stricture

114

661

1.73

7.15

3.6

3.7

—

Arthrosis

217

788

1.51

7.14

3.9

3.7

—

Other and unspecified tonsillitis

233

2.17

7.12

4.0

3.6

—

Other external causes of accidental injury

240

810

1.49

7.11

3.8

—

Shoulder lesions

235

963

1.48

7.11

3.6

3.8

—

Diseases of the eye and adnexa

193

621

1.56

7.11

3.9

3.7

—

Heartburn

163

2.53

7.07

3.0

4.3

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

269

2.17

7.07

3.0

4.2

—

Schizophrenia or delusion, excluding more controls

413

1.92

7.06

3.2

3.8

—

Hypotension

390

1.96

7.06

3.9

3.7

—

Disorders of eyelid, lacrimal system and orbit

264

1400

1.43

7.05

3.9

3.8

—

Assault

112

2.87

7.04

2.7

4.6

—

Other headache syndromes

107

612

1.75

7.02

3.6

3.9

—

160

930

1.58

7.01

3.9

3.6

—

Neurotic, stress-related and somatoform disorders

231

1100

1.47

6.96

3.8

3.9

—

Accidents

239

810

1.48

6.95

3.7

3.8

—

Wegener granulomatosis

8.41

6.86

2.4

5.9

—

Coxarthrosis

172

727

1.57

6.85

3.4

3.7

—

Congenital malformations of the respiratory system

8.37

6.84

3.8

6.9

—

Pain (limb, back, neck, head abdominally)

210

696

1.51

6.81

3.6

3.8

—

Insulin, fast-acting or short human

118

702

1.68

6.75

4.9

3.7

—

Viral hepatitis, IBD co-morbidity

5.65

6.75

2.8

3.5

—

Herpesviral [herpes simplex] infections

155

2.53

6.75

3.8

—

Postzoster neuralgia

7.30

6.74

3.7

3.8

—

Kidney transplant status

3.52

6.72

2.4

5.0

—

Atopic dermatitis, strict definition with reimbursement

303

2.04

6.71

6.4

3.7

—

Mental and behavioural disorders due to sedatives or hypnotics

3.51

6.71

3.0

5.0

—

Polymyalgia rheumatica

269

2.13

6.67

3.7

3.9

—

Disorders of lacrimal system

133

817

1.63

6.67

4.9

3.9

—

Acute laryngitis and tracheitis

3.50

6.67

7.0

3.8

—

Falls/tendency to fall

303

1083

1.40

6.66

3.9

3.8

—

Abnormal involuntary movements

218

2.26

6.63

3.4

4.4

—

Use of biperiden

3.58

6.59

2.7

4.7

—

Adult respiratory distress syndrome

8.87

6.59

2.5

6.1

—

Respiratory disorders in diseases classified elsewhere

8.86

6.59

3.1

5.7

—

Crohn's disease NAS

3.46

6.56

3.0

4.8

—

Non-follicular lymphoma

194

2.34

6.56

2.9

3.9

—

Sciatica+with lumbago

142

819

1.60

6.55

3.7

3.9

—

Urticaria

422

1.88

6.53

3.9

—

Sequelae of infectious and parasitic diseases

106

2.85

6.52

5.8

3.5

—

Acute and transient psychotic disorders

140

2.58

6.52

3.6

4.2

—

Actinic keratosis

150

886

1.57

6.45

3.7

3.6

—

Nerve, nerve root and plexus disorders

316

1409

1.37

6.45

3.6

3.8

—

Tobacco use

3.52

6.44

3.2

4.6

—

Artrosis, including avohilmo

251

958

1.44

6.42

3.6

3.8

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

126

766

1.63

6.39

3.4

3.8

—

Skin changes due to chronic exposure to nonionizing radiation

152

900

1.56

6.36

3.7

—

Other abnormal immunological findings in serum

8.24

6.35

5.0

6.1

—

Non-small cell lung cancer, adenocarcinoma

108

2.80

6.32

2.8

4.1

—

Fibrosis and cirrhosis of liver

125

2.66

6.31

3.4

4.2

—

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

+∞

6.31

3.3

0.0

—

Carcinoma in situ of skin of other and unspecified parts of face

198

2.29

6.28

3.4

3.7

—

Crohn disease

155

2.46

6.25

3.4

4.0

—

Coagulation defects, purpura and other haemorrhagic conditions

338

1.96

6.22

4.0

4.1

—

Mental and behavioural disorders due to opioids

6.30

6.16

3.4

5.0

—

Injury of other and unspecified intrathoracic organs

104

2.81

6.15

3.8

4.0

—

Congenital malformations of the respiratory system

7.77

6.14

3.8

6.9

—

Superficial injury of hip and thigh

285

2.04

6.13

3.6

4.2

—

Other diseases of intestine

272

2.07

6.12

3.9

4.0

—

Hypothyroidism, strict autoimmune

200

893

1.47

6.11

3.9

3.8

—

Alzheimer’s disease, strict definition

596

0.40

6.08

2.7

3.5

—

Kyphosis

10.19

6.06

4.9

2.7

—

Endocrine disorders, other/unspecified

6.77

6.05

3.5

4.7

—

Aortic aneurysm

102

591

1.70

6.05

3.2

3.7

—

Acute generalized exanthematous pustulosis

3.61

6.04

6.5

4.4

—

Dental pulpitis, including avohilmo

227

1027

1.44

6.04

4.0

3.9

—

Other viral diseases, not elsewhere classified

246

2.11

6.03

4.7

4.0

—

Glomerular disorders in diseases classified elsewhere

208

2.22

6.02

3.0

3.8

—

Spondyloarthritis

294

2.01

6.01

3.3

4.0

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

188

1265

1.47

6.00

3.9

3.8

—

Scoliosis

2.93

5.99

3.7

4.9

—

Atherosclerosis, excluding cerebral and coronary sclerosis

161

837

1.53

5.98

3.4

3.8

—

Other symptoms and signs involving the digestive system and abdomen

241

2.12

5.98

4.2

4.1

—

Viral and other specified intestinal infections

216

2.17

5.96

5.0

3.6

—

Hypersensitivity pneumonitis due to organic dust

7.36

5.95

4.8

5.8

—

Keratitis

105

629

1.67

5.93

4.8

3.8

—

Polypectomy (DHB20)

112

2.70

5.92

5.4

3.9

—

Diseases of middle ear and mastoid

141

738

1.56

5.90

4.6

3.8

—

Dizziness and giddiness

227

1268

1.42

5.90

3.9

3.8

—

Delirium, not induced by alcohol and other psychoactive substances

269

2.05

5.88

3.3

3.8

—

479

1.75

5.88

3.6

3.7

—

Benign neoplasm: Bronchus and lung

8.17

5.87

4.7

5.7

—

Myocardial infarction, without ST-elevation

157

943

1.52

5.87

3.6

3.7

—

Nephropathy related operations

217

2.18

5.86

3.0

4.0

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

140

899

1.55

5.83

3.1

3.7

—

Generalized skin eruption due to drugs and medicaments

3.81

5.82

6.7

4.6

—

Pulmonary eosinophilia, not elsewhere classified

9.37

5.82

2.8

6.3

—

Personal history of certain other diseases

11.23

5.80

5.5

5.1

—

Acute bronchiolitis

5.90

5.80

3.1

8.0

—

Insulin, combination of fast acting with intermediate-acting or long-acting

199

1260

1.45

5.80

4.2

3.7

—

Alzheimer disease, including avohilmo

761

0.52

5.79

3.1

3.6

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

195

1077

1.45

5.72

3.4

3.7

—

Diseases of the musculoskeletal system and connective tissue

124

380

1.64

5.70

4.1

—

Injuries to the elbow and forearm

191

1157

1.45

5.70

4.1

3.9

—

Diverticular disease of intestine

223

1001

1.42

5.68

3.7

3.8

—

Dialysis, with operation codes

227

2.12

5.65

3.1

4.1

—

Disorders of choroid and retina

257

1322

1.38

5.65

4.5

3.7

—

Cervical disc disorders

109

669

1.63

5.63

3.6

3.8

—

Symptoms and signs involving the skin and subcutaneous tissue

202

1384

1.43

5.62

4.0

3.8

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

3.13

5.62

3.6

3.9

—

ILD medications: acetylcysteine

13.14

5.61

5.0

3.4

—

Antihypertensive medication - note that there are other indications

105

328

1.70

5.60

3.6

3.9

—

Other viral hepatitis

3.55

5.60

2.8

4.8

—

Abnormal findings on examination of urine, without diagnosis

3.31

5.59

2.5

3.7

—

Neurological diseases, wide definition

127

2.14

5.55

5.3

3.7

—

Use of anticholinesterases

784

0.51

5.51

3.0

3.6

—

N06DA Anticholinesterases

784

0.51

5.51

3.0

3.6

—

Cutaneous abscess, furuncle and carbuncle

425

1.79

5.51

3.4

4.0

—

Other gastritis (incl. Duodenitis)

440

1.78

5.50

3.6

3.7

—

Other abnormal uterine and vaginal bleeding

233

1.94

5.49

3.4

4.2

—

Other and unspecified injuries of lower leg

3.07

5.49

4.1

4.4

—

Other intervertebral disc disorders

225

959

1.41

5.47

3.9

3.7

—

Alzheimer’s disease (Late onset)

556

0.41

5.46

2.7

3.6

—

Other abnormalities of plasma proteins

7.19

5.46

5.3

5.7

—

Mental and behavioural disorders due to alcohol

156

1005

1.49

5.45

3.1

3.8

—

Gastroduodenal ulcer

597

1.66

5.43

3.5

3.7

—

Alcohol use disorder, ICD-based

127

816

1.56

5.43

3.1

3.8

—

Hypertensive heart and/or renal disease

419

1.70

5.42

3.5

3.9

—

Haemorrhoids and perianal venous thrombosis

107

659

1.62

5.41

4.2

3.8

—

Mood disorders, excluding more controls

260

1129

1.38

5.40

3.7

3.8

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

148

667

1.52

5.39

3.8

4.0

—

Injuries to the shoulder and upper arm

246

1441

1.38

5.38

3.6

3.9

—

Need for other prophylactic measures

3.03

5.37

3.2

4.5

—

Voice disturbances

488

1.73

5.36

3.8

3.9

—

Medical observation and evaluation for suspected diseases and conditions

177

611

1.48

5.35

4.8

3.6

—

Abnormal findings on diagnostic imaging of other body structures

167

2.28

5.35

3.6

3.7

—

D07AA Corticosteroids, weak (group I)

173

2.26

5.35

3.7

4.8

—

Hypothyroidism, drug reimbursement

2.81

5.33

4.0

5.2

—

Disorders of magnesium metabolism

11.58

5.33

5.1

2.9

—

Acute drug-induced interstitial lung disorder

11.58

5.33

3.3

8.0

—

Hyperparathyroidism

318

1.90

5.32

3.6

3.8

—

Mantle cell lymphoma, including Hilmo

11.42

5.31

3.6

6.0

—

Alzheimer disease

680

0.50

5.30

3.1

3.6

—

Hypopituitarism

2.93

5.29

3.7

4.9

—

Diabetes medication

291

1282

1.35

5.29

4.1

3.8

—

Essential (haemorrhagic) thrombocythaemia

3.67

5.21

2.4

4.6

—

Giant cell arteritis

3.15

5.20

5.3

4.0

—

Purpura and other haemorrhagic conditions

235

2.05

5.19

4.0

3.9

—

Injury, poisoning and certain other consequences of external causes

143

465

1.54

5.19

4.2

4.3

—

Viral hepatitis

3.14

5.18

3.0

4.2

—

Assault by bodily force

3.14

5.18

2.8

5.3

—

Corneal ulcer

290

1.94

5.18

3.6

3.9

—

Diffuse large B-cell lymphoma, including Hilmo

3.25

5.17

2.9

4.1

—

Diffuse large B-cell lymphoma

3.25

5.17

2.9

4.1

—

Diffuse large B-cell lymphoma, helper endpoint

3.25

5.17

2.9

4.1

—

Symptoms and signs involving speech and voice

105

655

1.61

5.12

3.7

3.8

—

Common variable immunodeficiency

13.75

5.11

4.5

6.7

—

Myocarditis

3.77

5.08

3.5

2.8

—

Deviated nasal septum

571

1.65

5.08

5.2

3.5

—

Unspecified nephritic syndrome

5.72

5.08

2.9

4.8

—

conjunctival haemorrhage

128

2.44

5.04

3.8

3.7

—

Other diseases of oesophagus

192

2.15

4.99

4.3

3.9

—

In situ neoplasms

121

786

1.54

4.97

3.6

3.8

—

Other sleep disorders

160

2.26

4.97

4.3

3.9

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

3.70

4.96

7.1

6.6

—

Disorders of oesophagus in diseases classified elsewhere

5.07

4.96

4.2

4.8

—

Chronic ulcer of skin, not elsewhere classified

123

2.45

4.95

4.3

3.3

—

Other specific joint derangements/joint disorders

175

782

1.45

4.95

3.8

3.9

—

Mood disorders

272

1312

1.34

4.94

3.7

3.9

—

Kela-code for severe mental illness

576

1.64

4.94

3.1

3.9

—

Unspecified fall

149

998

1.47

4.92

3.9

3.8

—

Other epidermal thickening

3.14

4.92

3.4

—

Cirrhosis of liver, NAS

2.68

4.91

3.3

3.9

—

Cystitis

241

1047

1.37

4.91

4.1

3.8

—

Fentanyl

180

2.17

4.90

3.5

3.8

—

Other salmonella infections

3.51

4.90

5.6

3.8

—

Hernia of abdominal wall

140

942

1.49

4.88

3.5

3.7

—

Coxibs

311

1.66

4.88

3.9

—

Schizophrenia, schizotypal and delusional disorders

479

1.69

4.88

3.2

3.9

—

Disorders of muscles

155

2.27

4.88

5.2

4.7

—

Diseases of liver

108

687

1.58

4.88

3.9

3.7

—

119

672

1.55

4.85

3.6

3.7

—

Congenital malformations of trachea and bronchus

9.20

4.81

4.6

7.3

—

Mantle cell lymphoma

11.68

4.81

3.6

6.4

—

Other bacterial agents as the cause of diseases classified to other chapters

9.19

4.81

7.9

8.1

—

Ankylosing spondylitis

119

2.45

4.79

4.3

3.6

—

Presence of cardiac and vascular implants and grafts

141

703

1.49

4.78

3.1

3.5

—

Gonarthrosis [arthrosis of knee](FG)

216

905

1.39

4.78

3.9

3.7

—

Ulcerative colitis, NAS

189

2.12

4.77

4.1

3.8

—

Other condition

209

2.06

4.77

4.7

4.3

—

Alcohol use disorder, Swedish definition

169

1084

1.43

4.77

3.0

3.8

—

Other viral diseases, not elsewhere classified

347

1.81

4.76

4.5

3.9

—

Viral warts

292

1.89

4.75

4.3

4.2

—

Gastric ulcer

380

1.77

4.70

3.4

3.7

—

Other endocrine disorders

3.42

4.70

4.0

6.0

—

Alcohol dependence

515

1.65

4.69

2.8

4.0

—

Schizophrenia or delusion

477

1.68

4.69

3.2

3.9

—

Benign neoplasm of other and unspecified endocrine glands

231

2.00

4.68

3.8

4.2

—

Mood [affective] disorders

269

1310

1.33

4.67

3.7

3.9

—

Urethral stricture

127

2.38

4.65

3.8

3.6

—

Fracture of lumbar spine and pelvis

440

1.71

4.65

3.1

3.7

—

Hypercalcemia

3.13

4.64

2.8

4.6

—

Other and unspecified vasculitis limited to skin

5.06

4.64

4.2

3.7

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

238

1.98

4.64

2.9

4.1

—

Carcinoma in situ of skin, other sites/unspecified

6.22

4.62

3.5

5.9

—

Basal cell carcinoma, including avohilmo

144

672

1.48

4.62

3.9

4.0

—

Other specified disorders of kidney and ureter

3.52

4.62

5.3

4.2

—

Other abnormal findings in urine

6.20

4.62

2.9

5.1

—

Scabies

3.51

4.61

4.2

7.1

—

Intussusception

5.52

4.61

4.8

5.5

—

Other specified/unspecified disorders of bone/cartilage

5.50

4.61

3.2

4.5

—

Allergic urticaria

2.76

4.61

4.2

3.6

—

Malignant neoplasm of larynx

8.29

4.57

3.9

5.2

—

Other disorders of kidney and ureter

254

1.94

4.57

4.9

3.9

—

Vasculitis limited to skin, not elsewhere classified

4.57

4.56

4.4

3.5

—

Alcohol withdrawal state with delirium

122

2.39

4.56

2.3

3.8

—

Protein-energy malnutrition of moderate and mild degree

10.21

4.54

2.9

8.3

—

Schizophrenia

200

2.06

4.52

2.7

4.0

—

Basal cell carcinoma

139

651

1.48

4.49

3.9

4.0

—

Peritonsillar abscess

228

1.98

4.47

3.0

3.7

—

Other retinal disorders

206

1172

1.37

4.46

4.6

3.7

—

Pyogenic arthritis

2.54

4.46

3.1

3.3

—

Dissociative [conversion] disorders

5.25

4.46

2.7

5.3

—

Genitourinary diseases

147

499

1.48

4.45

4.0

3.7

—

Acute suppurative otitis media

206

2.00

4.44

6.1

3.8

—

Cholecystitis

285

1.87

4.44

2.9

4.0

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

130

2.32

4.43

2.8

3.5

—

Superficial injury of abdomen, lower back and pelvis

229

1.97

4.43

3.5

4.3

—

Seronegative rheumatoid arthritis

175

2.12

4.43

3.6

4.3

—

180

1137

1.40

4.42

3.0

3.8

—

Cholecystectomy

207

1310

1.36

4.42

3.7

3.8

—

Radiculopathy

307

1.83

4.42

3.9

4.0

—

Otitis media, unspecified

2.65

4.41

6.2

3.6

—

Inflammatory bowel disease

532

1.62

4.40

4.2

3.8

—

Acute pancreatitis

388

1.73

4.40

3.4

4.0

—

Amenorrhoea

4.07

4.40

4.7

4.5

—

Other noninfective gastroenteritis and colitis

433

1.69

4.38

4.2

3.7

—

Other and unspecified rosacea

112

2.42

4.38

4.3

—

Unspecific neurodegenerative disorder

854

0.61

4.33

3.0

3.7

—

Unspecified mental disorder

636

1.56

4.32

3.0

3.9

—

Chronic viral hepatitis

3.35

4.32

2.8

4.5

—

Idiopathic gout

204

2.02

4.31

3.9

3.7

—

Malignant neoplasm of skin

151

718

1.44

4.31

3.7

3.9

—

Spondylopathies (FG)

177

2.10

4.31

3.8

4.5

—

Malnutrition

5.56

4.30

2.7

5.5

—

Infections of the skin and subcutaneous tissue

152

1057

1.43

4.29

4.0

3.9

—

Other immunodeficiencies

11.84

4.29

7.3

3.0

—

Malignant neoplasm of thyroid gland

2.79

4.28

6.0

4.8

—

Benign neoplasm: Adrenal gland

126

2.31

4.26

4.1

3.9

—

Viral and other specified intestinal infections

313

1.79

4.26

5.0

3.7

—

L01XX Other antineoplastic agents

108

2.42

4.22

3.5

3.7

—

Fracture of femur

579

1.55

4.22

3.2

3.8

—

Benign neoplasm: Pancreas

3.89

4.20

5.7

4.2

—

Nonischemic cardiomyopathy

159

2.15

4.19

3.3

3.8

—

Occupational exposure to risk-factors

3.29

4.19

3.3

3.5

—

Vitamin deficiency

2.92

4.17

4.3

4.5

—

Vitamin deficiency, wide

2.92

4.17

4.3

4.5

—

Other keratitis

140

2.22

4.17

3.5

4.1

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

170

1224

1.39

4.15

3.9

—

Tuberculosis of other organs, strict

4.38

4.13

2.6

4.5

—

Other and unspecified epidermal thickening

4.38

4.13

3.3

3.6

—

Entropion and trichiasis of eyelid

187

2.04

4.13

3.6

3.7

—

Other diseases of blood and blood-forming organs

2.49

4.13

2.8

3.7

—

Degenerative diseases of the nervous system

749

0.59

4.12

3.4

3.7

—

Diabetic nephropathy, excluding more controls

198

1.92

4.07

3.0

3.6

—

Superficial injury of forearm

110

2.37

4.06

2.9

4.8

—

Malignant neoplasm of endocrine gland

2.64

4.06

5.8

5.4

—

Use of donepezil

503

0.44

4.06

2.8

3.6

—

Pain in joint

143

633

1.44

4.04

3.8

3.9

—

Other disorders involving the immune mechanism, not elsewhere classified

4.23

4.02

3.6

5.5

—

Superficial injury of thorax

252

1.87

4.01

3.1

3.7

—

Benign neoplasm: Tongue

3.93

4.00

4.7

4.4

—

Chronic pancreatitis

231

1.91

4.00

6.0

3.9

—

Other bacterial agents as the cause of diseases classified to other chapters

6.53

4.00

7.9

6.5

—

Psoriasis (vulgaris), strict definition

3.92

4.00

4.1

4.8

—

Mature T/NK-cell lymphomas, hilmo

6.53

4.00

3.0

6.1

—

Vulvovaginal ulceration/inflammation in other diseases

3.90

3.99

3.2

3.9

—

Heterophoria

2.68

3.98

3.8

5.4

—

Other/unspecified cytomegaloviral diseases

5.62

3.98

2.5

5.4

—

Papulosquamous disorders

110

738

1.49

3.98

3.6

3.9

—

Carcinoma in situ of skin of scalp and neck

3.06

3.98

3.8

3.7

—

Other salmonella infections

3.04

3.96

5.6

3.7

—

Ocular pain

2.48

3.96

3.3

5.0

—

Mixed and other personality disorders

2.82

3.95

4.1

4.2

—

Missing teeth due to accident, extraction or parodontitis

181

1252

1.36

3.95

3.7

3.8

—

Leisure time condition

304

1.78

3.95

4.0

—

Other neurological diseases

224

1330

1.32

3.94

3.6

3.8

—

Soft tissue disorders related to use, overuse and pressure

470

1.62

3.94

4.6

4.1

—

Papillary adenocarcinoma of thyroid gland

3.14

3.93

7.3

5.5

—

Familial hypercholesterolemia

327

1.75

3.91

3.5

3.9

—

Other skin changes

365

1.70

3.89

4.0

3.7

—

Disorders of skin appendages

114

774

1.47

3.87

3.7

3.9

—

Convulsions, not elsewhere classified

309

1.76

3.87

3.3

4.0

—

Rosacea

158

2.10

3.87

4.2

4.3

—

Other diseases of pancreas

145

2.15

3.86

3.5

4.3

—

Unspecified kidney failure

213

1.93

3.86

3.3

3.7

—

Artificial joint operation, meniscal resection

271

1364

1.29

3.85

4.1

3.7

—

Polyarteritis nodosa and related conditions

6.08

3.83

3.0

6.1

—

Tuberculosis of other organs

4.33

3.83

2.4

4.2

—

9.06

3.81

3.9

8.0

—

Thrombocytopenia, unspecified

120

2.26

3.80

3.5

4.0

—

Disorders of parathyroid gland, other and/or unspecified

8.96

3.79

3.6

6.3

—

Other and unspecified aplastic anaemias

8.87

3.78

3.1

8.0

—

Malignant neoplasm of hypopharynx, including Hilmo

12.25

3.78

4.5

7.6

—

Herpesviral [herpes simplex] infections

353

1.70

3.78

3.8

4.0

—

Psoriasis vulgaris

316

1.75

3.77

3.3

3.8

—

Benign neoplasms

261

1109

1.30

3.77

4.3

3.7

—

Lumbar disc prolapse

162

900

1.38

3.75

3.6

3.8

—

Other diseases of lip and oral mucosa

108

732

1.48

3.74

3.7

3.9

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

463

1.60

3.74

3.3

4.0

—

Paracetamol or NSAID medication

110

1.97

3.73

4.9

3.9

—

Abdominal aortic aneurysm (AAA)

271

1.80

3.72

3.4

—

170

1128

1.36

3.71

3.1

3.8

—

Malignant neoplasm of larynx, including Hilmo

5.05

3.69

4.2

4.6

—

Benign neoplasm: Parathyroid gland

6.78

3.69

3.5

7.1

—

Poisoning by drugs, medicaments and biological substances

289

1.77

3.67

3.5

4.2

—

Other superficial mycoses

5.67

3.66

4.2

4.6

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

109

737

1.47

3.66

3.7

3.8

—

Disorders of continuity of bone

103

2.34

3.66

4.5

4.9

—

Transient ischemic attack

173

1032

1.36

3.65

3.6

3.8

—

Dialysis

2.88

3.63

2.3

4.2

—

IgA nephropathy (IgA glomerulonephritis)

4.44

3.63

3.5

5.8

—

Depression

236

1229

1.30

3.63

3.7

3.9

—

Malignant neoplasm of thyroid gland, including Hilmo

2.48

3.63

5.9

5.2

—

DVT of lower extremities

388

1.65

3.62

3.0

3.6

—

Benign neoplasm of middle ear and respiratory system

149

2.09

3.62

3.7

4.0

—

Irregular menses

389

1.58

3.61

4.3

4.1

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

4.03

3.60

3.7

5.4

—

Other enthesopathies

482

1.58

3.59

3.7

4.2

—

Maltreatment syndromes

3.73

3.59

2.9

7.2

—

ILD and respiratory illness in diseases classified elsewhere

8.02

3.59

3.9

7.4

—

Other arthrosis

147

730

1.40

3.58

3.5

3.7

—

Explicit fungal Sepsis

7.96

3.58

5.4

7.9

—

!Aliquae complicationes praecoces traumatis

2.96

3.57

4.3

4.4

—

Early complications of trauma

2.96

3.57

4.3

4.4

—

Postmenopausal osteoporosis with pathological fracture

2.36

3.57

3.3

4.1

—

Acute pancreatitis (for exclusion)

413

1.63

3.56

3.4

3.8

—

Other follicular disorders

2.58

3.54

4.3

4.4

—

Disorders of lipoprotein metabolism and other lipidaemias

228

1082

1.31

3.54

3.2

3.8

—

Rotator cuff syndrome

175

929

1.35

3.54

3.8

—

Diseases of salivary glands

555

1.53

3.54

3.9

4.0

—

Phlebitis and thrombophlebitis (not including DVT)

414

1.62

3.53

3.6

3.7

—

Other disorders of bone

278

1.77

3.53

3.2

4.1

—

Scleritis and episcleritis

2.82

3.52

3.1

4.8

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

206

1.90

3.52

5.3

4.0

—

Disorders of optic nerve and visual pathways

105

2.29

3.52

8.9

4.8

—

Cytomegalovirus infection, IBD co-morbidity

4.27

3.51

2.9

4.1

—

Failure and rejection of transplanted organs and tissues

6.23

3.51

7.8

3.2

—

Disorders of synovium and tendon

132

822

1.41

3.51

3.6

4.0

—

Ankylosing spondylitis, ICD10

118

2.21

3.50

4.2

3.8

—

Injuries to the ankle and foot

159

1037

1.36

3.50

3.6

4.0

—

Necrosis of pulp, including avohilmo

134

956

1.40

3.50

4.8

3.8

—

Excessive earwax

163

1176

1.35

3.47

4.0

3.8

—

Calcific aortic valvular stenosis, operated

112

753

1.45

3.47

3.1

3.7

—

Calcific aortic valvular stenosis

112

753

1.45

3.47

3.1

3.7

—

Calcific aortic valvular stenosis, diagnosis (helper)

112

753

1.45

3.47

3.1

3.7

—

Operations 2 for CAVS

112

753

1.45

3.47

3.1

3.7

—

Gonarthrosis

182

770

1.35

3.46

4.1

3.7

—

Other anxiety disorders

502

1.52

3.46

4.8

4.1

—

Artificial opening status

2.55

3.46

3.9

3.3

—

Lesion of ulnar nerve

236

1.83

3.46

3.5

3.8

—

Varicella [chickenpox]

2.89

3.46

2.9

6.3

—

Suppurative and unspecified otitis media

389

1.60

3.42

5.0

3.7

—

Disorders of orbit

2.99

3.41

3.2

4.9

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

243

1241

1.29

3.40

3.8

3.9

—

Other and unspecified injuries of ankle and foot

3.53

3.40

6.5

5.6

—

Glaucoma

183

1187

1.33

3.38

3.8

3.7

—

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

5.05

3.38

2.1

4.2

—

Acute and subacute iridocyclitis

327

1.69

3.37

3.2

4.0

—

Spondylolisthesis/Spondylolysis

297

1.72

3.37

4.3

4.0

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

308

1.70

3.37

3.4

4.0

—

Iridocyclitis

396

1.62

3.37

3.1

3.9

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

260

1.77

3.37

5.0

3.9

—

Acute epiglottitis

7.07

3.37

3.7

5.8

—

Disorders of conjunctiva

199

1218

1.31

3.36

3.9

—

Universal erythroderma, KELA reimbursement

5.78

3.35

3.9

5.4

—

Calcific aortic valvular stenosis, including rheumatic fever

112

758

1.43

3.35

3.1

3.7

—

Anterior Iridocyclitis

351

1.66

3.33

3.2

4.1

—

Other diseases of hard tissues of teeth

170

649

1.36

3.33

4.6

3.7

—

Inflammatory diseases of female pelvic organs

118

608

1.43

3.33

4.0

4.1

—

Discitis, unspecified

4.40

3.32

2.1

3.1

—

Alcohol-induced chronic pancreatitis

108

2.23

3.32

2.9

4.0

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

133

756

1.39

3.31

3.6

3.9

—

Varicella [chickenpox]

2.93

3.30

2.9

6.4

—

Hodgkin lymphoma, hilmo

3.96

3.29

3.4

4.8

—

Unstable angina pectoris

117

649

1.42

3.29

3.6

—

Other congenital malformations

2.54

3.28

3.4

5.7

—

Preterm labour and delivery

293

1.71

3.24

4.1

4.4

—

Irritable bowel syndrome

416

1.59

3.24

3.6

4.0

—

Hypothyroidism, other/unspecified

235

1207

1.28

3.23

3.8

—

Insulin, intermediate and long-acting

162

1177

1.34

3.23

3.7

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

163

1.97

3.23

3.3

3.8

—

Other and unspecified psoriasis

103

2.24

3.22

4.1

3.9

—

Pediculosis, acariasis and other infestations

2.59

3.21

4.0

5.6

—

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

6.44

3.19

7.4

6.9

—

Dilated cardiomyopathy

250

1.77

3.19

2.9

3.9

—

Cytomegaloviral disease

3.83

3.19

2.9

4.8

—

Pain in thoracic spine

221

1.81

3.17

3.6

4.1

—

Use of other anti-dementia drugs

631

0.59

3.17

3.1

3.6

—

Use of memantine

631

0.59

3.17

3.1

3.6

—

Spirochaetal infections, other/unspecified

567

0.53

3.16

3.7

3.8

—

Malignant neoplasm of head and neck

137

2.05

3.16

3.4

4.3

—

Other disorders of cornea

144

2.02

3.15

7.4

4.2

—

Polyarthritis, unspecified

3.27

3.14

3.5

3.1

—

Menorrhagia

253

1.58

3.14

4.0

4.1

—

Other spirochaetal diseases

565

0.53

3.12

3.7

3.8

—

Bacterial, viral and other infectious agents

2.25

3.12

9.5

3.9

—

IBD patients in KELA-register

327

1.65

3.12

4.6

3.7

—

Other disorders of conjunctiva

267

1.73

3.11

3.6

4.0

—

Alcohol abuse, main dg, excluding more controls

201

1.85

3.10

2.9

4.0

—

Ischaemic Stroke, excluding all haemorrhages

184

1045

1.31

3.10

3.6

3.7

—

Inflammatory bowel disease, strict (require KELA)

328

1.65

3.09

4.6

3.9

—

Chronic periodontitis, including avohilmo

263

1406

1.25

3.07

3.8

—

Other and unspecified nonorganic psychotic disorders

209

1.82

3.07

3.2

4.4

—

Other nonthrombocytopenic purpura

7.61

3.06

3.0

8.6

—

Other spirochaetal diseases

574

0.54

3.06

3.7

3.8

—

Cardiomyopathy, other and unspecified

112

2.15

3.06

3.0

4.2

—

Complications following infusion, transfusion and therapeutic injection

5.05

3.06

2.6

4.9

—

Other orthopaedic follow-up care

2.69

3.05

3.3

4.8

—

Ankylosing spondylitis, strict definition

3.19

3.05

3.5

4.3

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

139

2.02

3.05

3.0

4.6

—

Lyme disease

560

0.53

3.05

3.7

3.8

—

Otitis externa, unspecified

146

1.99

3.04

3.6

4.0

—

Other diseases of biliary tract

153

1.97

3.04

2.9

4.3

—

Persistent mood disorders

299

1.68

3.04

4.0

4.1

—

Viral warts

119

2.11

3.03

5.0

4.8

—

Malignant immunoproliferative diseases

5.93

3.03

4.1

7.3

—

Other prurigo

5.91

3.03

4.6

6.8

—

Malignant neoplasm of heart, mediastinum and pleura

5.90

3.03

2.0

5.3

—

Other and unspecified coagulation defects

2.90

3.02

4.8

4.2

—

Nephrotic syndrome

3.36

3.02

3.8

4.7

—

Rapidly progressive nephritic syndrome

10.48

3.01

4.8

10.2

—

Periodontitis

263

1407

1.25

3.00

3.8

—

Other coagulation defects

2.31

3.00

4.1

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

240

1.75

3.00

5.1

3.9

—

Pustular psoriasis

2.76

2.98

2.7

4.1

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

168

1.91

2.98

3.0

4.1

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

3.86

2.98

5.7

6.0

—

Excessive, frequent and irregular menstruation

262

1.55

2.97

3.9

4.0

—

Bacterial, viral and other infectious agents

107

2.16

2.96

9.3

3.9

—

Inguinal hernia

175

891

1.31

2.96

4.0

3.6

—

Abnormalities of gait and mobility

234

1.76

2.95

3.4

4.3

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

216

1144

1.28

2.93

3.9

—

Unspecified visual impairment (binocular)

4.75

2.92

2.0

6.9

—

Alcohol abuse counselling and surveillance

4.75

2.92

3.0

4.4

—

Chronic tubulo-interstitial nephritis

2.84

2.92

2.6

4.0

—

Cardiac arrest

2.36

2.92

3.4

4.1

—

Other (not insulin) diabetes medications

265

1261

1.25

2.92

3.5

3.8

—

Ventral hernia

476

1.52

2.91

3.5

3.6

—

Chorioretinal inflammation

3.46

2.90

3.2

4.3

—

Thoracic aortic aneurysm

311

1.65

2.90

3.0

3.7

—

Pain associated with micturition

199

1.81

2.88

3.0

4.7

—

Intercostal neuropathy

6.78

2.88

2.3

5.1

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

6.76

2.88

6.2

7.2

—

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

6.75

2.88

3.0

5.9

—

Benign neoplasm: Scapula and long bones of upper limb

6.75

2.87

3.3

7.0

—

Crohn's disease of small intestine

2.44

2.87

2.5

4.7

—

Malignant cancer of tonsil and base of tongue

5.42

2.87

3.0

4.8

—

Iron deficiency

5.41

2.87

2.6

6.8

—

Atopic dermatitis, strict definition

290

1.66

2.87

5.7

3.9

—

Ulcerative colitis (strict definition, require KELA)

222

1.76

2.84

5.3

3.9

—

Conjunctivitis (acute, non atopic)

413

1.55

2.84

4.0

—

Oxicams

303

1.50

2.83

3.7

3.6

—

Raynaud syndrome

2.19

2.83

3.2

4.3

—

Open wound of lower leg

245

1.72

2.82

5.5

4.3

—

Anaemia in chronic diseases classified elsewhere

3.36

2.81

3.9

4.5

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

337

1.61

2.81

3.7

4.3

—

Abnormal findings on diagnostic imaging of central nervous system

3.35

2.81

5.2

5.5

—

Hypertensive Heart Disease

405

1.49

2.80

3.6

3.9

—

Parapsoriasis

4.48

2.80

3.9

5.8

—

Primary open-angle glaucoma, strict

618

1.44

2.80

3.6

3.7

—

Disease of hard tissues of teeth, NOS

151

591

1.34

2.78

4.4

3.7

—

Acute peritonitis

110

2.10

2.78

3.3

4.3

—

Sleep disorders

212

1209

1.27

2.78

3.9

—

Disorders of tooth development and eruption

138

1.88

2.78

4.0

3.4

—

Familial hypercholesterolemia, with ischemic heart disease

180

1.84

2.77

3.5

3.3

—

Umbilical hernia

506

1.48

2.77

3.5

3.6

—

Malignant neoplasm of nasal cavity and sinuses

8.48

2.76

2.2

6.5

—

Other disorders of veins

107

767

1.39

2.76

4.0

3.9

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

8.46

2.76

4.6

7.7

—

Elevated blood glucose level

124

2.02

2.75

3.9

4.0

—

Vascular disorders of the intestines

138

1.96

2.74

4.2

4.1

—

Gingivitis and periodontal diseases

283

1186

1.23

2.74

4.2

3.8

—

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

5.06

2.73

4.3

5.2

—

Osteonecrosis due to drugs

5.05

2.73

2.4

6.5

—

Myositis

3.26

2.73

2.9

3.9

—

Glaucoma suspect

110

800

1.38

2.71

3.9

3.7

—

Spinal osteochondrosis

6.07

2.70

2.0

2.8

—

Other acute viral hepatitis

6.06

2.70

2.5

6.3

—

Oesophagitis

2.25

2.70

3.5

3.8

—

Lichen simplex chronicus and prurigo

2.24

2.70

4.4

4.0

—

Ulcerative colitis

396

1.54

2.70

4.5

3.6

—

Other specified and unspecified personality disorders

2.24

2.70

2.8

4.0

—

Disorders of thyroid, IBD co-morbidities

110

1.92

2.70

4.4

3.8

—

Pure hypercholesterolaemia

203

1043

1.27

2.69

3.2

3.8

—

Allergic purpura

3.47

2.69

6.1

5.6

—

Acute myeloid leukaemia and myelodysplastic syndromes

4.24

2.68

3.0

4.2

—

Burn and corrosion of hip and lower limb, except ankle and foot

4.24

2.68

10.3

5.1

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

4.23

2.68

3.0

5.4

—

Psoriasis

518

1.47

2.68

3.4

3.8

—

Duodenal ulcer

242

1.70

2.66

3.4

3.5

—

Varicose veins

181

1066

1.28

2.65

3.8

3.9

—

Ulcer of oesophagus

140

1.94

2.65

4.7

3.6

—

Disturbances of skin sensation

406

1.53

2.64

4.2

3.8

—

Vertical strabismus

3.16

2.64

2.6

5.1

—

Insomnia

201

1157

1.27

2.64

3.9

—

Multiple myeloma, including Hilmo

2.40

2.63

3.6

4.6

—

Hyperfunction of pituitary gland

2.94

2.62

4.1

3.9

—

Other Crohn's disease

2.47

2.61

3.8

4.6

—

Infective dermatitis

191

1.79

2.61

3.2

3.8

—

Biguanides

260

1287

1.23

2.61

3.5

3.8

—

Primary adrenocortical insufficiency

4.73

2.60

5.6

5.9

—

Family history of certain disabilities and chronic diseases leading to disablement

3.34

2.60

8.6

4.6

—

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

4.70

2.60

2.7

5.1

—

Hypocalcemia

3.63

2.58

3.2

4.8

—

Other osteochondropathies

2.30

2.57

2.7

5.1

—

Contact with other hot fluids

3.62

2.57

9.2

5.9

—

Cluster headache, strict

3.62

2.57

4.4

6.2

—

Other operation for atrial fibrillation

7.31

2.56

3.0

8.4

—

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

7.24

2.56

2.2

9.0

—

Personal history of allergy to drugs, medicaments and biological substances

7.21

2.55

4.8

5.3

—

Hypertrophy of (infrapatellar) fat pad

5.52

2.55

4.2

5.1

—

Haemolytic anaemias

2.87

2.55

3.6

4.3

—

Gonarthrosis, primary, with knee surgery

183

1146

1.27

2.55

4.4

3.7

—

Bipolar affective disorders

200

1.75

2.55

3.2

4.2

—

Subjective visual disturbances

426

1.51

2.55

3.4

3.8

—

Use of rivastigmine

370

0.48

2.54

2.8

3.5

—

Cerebrovascular diseases

222

1253

1.25

2.54

3.4

3.7

—

Other disorders of Eustachian tube

3.25

2.52

5.7

4.6

—

Stroke, excluding SAH

189

1090

1.27

2.51

3.6

3.7

—

Poisoning by medicine

254

1.66

2.50

3.6

4.1

—

Chronic suppurative otitis media, including avohilmo

115

2.01

2.50

3.4

4.8

—

Cyst of kidney

129

1.95

2.50

4.6

4.0

—

Injury of muscle and tendon at hip and thigh level

136

1.92

2.50

3.5

4.0

—

Reactive arthropathies

122

1.97

2.50

4.5

4.1

—

Other inflammation of eyelid

224

1.70

2.49

3.7

4.0

—

Peripheral retinal degeneration

2.99

2.49

8.3

4.5

—

Adhesive capsulitis of shoulder

301

1.60

2.49

3.6

4.1

—

Spondylopathies in diseases classified elsewhere

4.43

2.48

2.1

3.4

—

Cluster headache, wide

3.47

2.48

4.4

6.3

—

Hyperplasia of prostate

124

523

1.35

2.48

4.3

3.4

—

Chronic diseases of tonsils and adenoids

150

726

1.31

2.48

3.7

3.6

—

Peripheral arterial reconstruction

421

1.50

2.47

3.2

3.6

—

Diseases of peritoneum

180

1.78

2.47

3.4

4.1

—

Deficiency of other B group vitamins

3.84

2.46

5.1

5.2

—

3.83

2.46

3.1

5.2

—

Episcleritis

2.68

2.45

3.2

4.8

—

Attention to artificial openings

2.47

2.45

4.4

3.6

—

Motor neuron disease (with DMD)

3.15

2.44

1.9

4.5

—

Use of pramipexole

439

1.48

2.43

3.7

3.9

—

malignant neoplasm of male genital organs

409

1.40

2.43

3.2

3.9

—

Stroke, including SAH

195

1127

1.26

2.42

3.6

3.8

—

Other strabismus

302

1.59

2.42

3.4

4.2

—

Other dialysis

2.91

2.41

2.2

4.8

—

Superficial injury of head

391

1.51

2.41

3.2

3.9

—

Hypertension, Pulmonary Arterial

5.07

2.41

8.7

5.6

—

Lifestyle-related condition

5.05

2.41

2.8

5.2

—

Other factor of the environment

5.05

2.41

2.8

4.9

—

Mesothelioma, including Hilmo

5.05

2.41

1.5

5.3

—

Myeloproliferative diseases (CML excluded)

131

1.92

2.40

2.6

3.6

—

Dermatophytosis

242

1.66

2.40

4.0

3.5

—

Acidosis

3.36

2.39

2.6

3.3

—

Primary coxarthrosis, bilateral

665

1.39

2.39

3.6

3.8

—

Generalized anxiety disorder

124

1.94

2.39

2.8

4.8

—

Strabismus

415

1.49

2.39

3.3

4.0

—

Presbyopia

2.35

2.38

5.8

4.0

—

Pyoderma gangrenosum

6.34

2.38

5.0

7.3

—

Collapsed vertebra, not elsewhere classified

6.33

2.38

4.6

3.4

—

Congenital malformations of anterior segment of eye

6.33

2.38

4.8

7.6

—

Benign neoplasm of other and unspecified intrathoracic organs

6.31

2.38

3.2

8.3

—

Malignant neoplasm of tonsil

6.30

2.37

2.8

6.0

—

Malignant neoplasm of oropharynx

6.29

2.37

2.8

6.0

—

Speech therapy

529

0.58

2.37

3.1

3.9

—

Heart failure and hypertrophic cardiomyopathy

3.67

2.37

5.1

5.2

—

Cervicocranial syndrome

146

1.85

2.36

4.0

4.2

—

Malignant neoplasm of oropharynx, including Hilmo

4.15

2.36

2.9

5.4

—

Infective bursitis

2.63

2.36

2.3

4.7

—

Nummular dermatitis

139

1.88

2.36

5.2

3.8

—

Behavioural syndromes associated with physiological disturbances and physical factors

218

1251

1.24

2.36

3.9

—

Subacute thyroiditis

3.04

2.36

5.6

3.9

—

Injury of muscle and tendon at wrist and hand level

198

1.72

2.34

3.6

4.1

—

Persons encountering health services for specific procedures, not carried out

2.15

2.34

6.7

4.1

—

Other or ill-defined heart diseases

2.26

2.34

2.7

4.1

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

154

1.82

2.33

3.7

—

Conjunctivitis

164

1077

1.27

2.33

3.9

4.0

—

Benign neoplasm of mouth and pharynx

184

1.74

2.31

3.7

4.0

—

Degeneration of nervous system due to alcohol

3.24

2.31

2.3

5.5

—

Manic episode

3.23

2.31

4.2

5.0

—

SLE (Finngen)

3.23

2.31

3.3

4.1

—

Diseases of tongue

2.19

2.31

2.9

3.6

—

Other and unspecified injuries of wrist and hand

3.23

2.31

4.1

4.8

—

Acute gastritis

126

1.91

2.30

3.0

3.9

—

Use of disulfiram, acamprosate or naltrexone

112

1.97

2.30

2.5

3.8

—

Temporal arteritis

2.39

2.29

6.5

4.1

—

Chronic iridocyclitis

2.38

2.29

3.3

3.9

—

Other female pelvic inflammatory diseases

192

1.72

2.29

4.5

4.2

—

Recurrent or chronic depression

385

1.43

2.29

4.4

3.9

—

Other diseases of liver

316

1.55

2.28

4.8

3.9

—

Other and unspecified erythematous conditions

2.96

2.28

3.8

4.4

—

Myeloproliferative diseases

148

1.83

2.28

2.6

3.8

—

Visual disturbances and blindness

135

1042

1.30

2.28

4.6

3.7

—

Squamous cell neoplasms and carcinomas of the skin

148

1.83

2.27

2.7

4.0

—

Marginal zone B-cell lymphoma, including Hilmo

4.65

2.27

2.8

5.4

—

Disorders of the thyroid gland

246

1317

1.22

2.27

3.6

3.8

—

Other and unspecified follicular disorders

2.76

2.27

5.3

4.0

—

Aphakia

4.64

2.27

3.0

5.7

—

Disorders of synovium and tendon in diseases classified elsewhere

3.50

2.27

2.8

4.2

—

Congenital malformations, deformations and chromosomal abnormalities

122

884

1.31

2.27

3.8

4.0

—

Fracture of shoulder and upper arm

688

1.37

2.27

3.6

3.8

—

Diseases of spleen

3.92

2.25

2.3

4.5

—

Panhypopituitarism

3.92

2.25

2.9

4.7

—

Seborrhoeic dermatitis

156

1.80

2.25

3.7

4.0

—

Type 1 diabetes

373

1.50

2.24

5.3

3.7

—

Malignant neoplasm of prostate

403

1.38

2.23

3.4

3.9

—

Injuries to the knee and lower leg

304

1415

1.19

2.23

3.7

3.9

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

581

1.40

2.23

3.3

4.0

—

Rash and other nonspecific skin eruption

142

1.84

2.22

4.7

4.4

—

Anankastic personality disorder

3.12

2.22

3.3

4.1

—

Benign neoplasm: Endocrine pancreas

5.65

2.22

4.2

8.3

—

Cellulitis

399

1.48

2.22

4.2

4.0

—

Polyuria

473

1.44

2.22

3.8

4.0

—

Corticotropin deficiency

5.63

2.22

5.2

6.8

—

Primary open-angle glaucoma

104

751

1.34

2.22

3.6

3.7

—

Benign neoplasm: Bladder

5.61

2.22

2.2

8.3

—

Other nutritional anaemias

5.60

2.21

4.8

5.1

—

Chronic suppurative otitis media

2.05

2.21

3.6

—

Pain and other conditions associated with female genital organs and menstrual cycle

164

1.74

2.21

2.9

4.0

—

Stomatitis and related lesions

303

1.55

2.20

3.6

4.3

—

Nail disorders

100

2.01

2.20

3.4

5.0

—

Congenital malformations of eye, ear, face and neck

2.41

2.19

3.6

6.5

—

Other specified and unspecified retinal disorders

2.51

2.19

3.5

4.2

—

Benign neoplasm: Skin of trunk

2.51

2.18

3.4

4.1

—

Other/unspecified enthesopathies, not elsewhere classified

143

1.82

2.18

4.0

4.6

—

Psoriatic and enteropathic arthropathies

165

1.76

2.18

3.3

4.2

—

Primary biliary cholangitis (PBC)

3.36

2.18

3.4

4.3

—

Hypermetropia

2.13

2.18

3.1

5.1

—

Other embolism and thrombosis

234

1.63

2.16

3.6

3.9

—

Visual disturbances

123

946

1.30

2.16

4.7

3.7

—

Operations for atrial fibrillation

3.72

2.15

3.0

4.9

—

Scleritis

4.32

2.15

2.7

5.9

—

Assault by blunt object

4.32

2.15

2.0

6.9

—

Helminthiases

4.31

2.15

2.5

6.9

—

Ulcer of lower limb, not elsewhere classified

305

1.54

2.15

3.6

3.7

—

Degeneration of the brain due to alcohol

3.02

2.15

2.3

5.3

—

Systemic lupus erythematosus, unspecified

3.02

2.15

3.3

5.2

—

Giant cell arteritis with polymyalgia rheumatica

2.31

2.15

6.5

4.0

—

Vascular diseases of the intestine

2.17

2.14

4.8

3.5

—

Cluster headache, strict, including avohilmo

2.63

2.14

4.2

4.9

—

Other congenital malformations of skin

2.79

2.14

3.4

7.1

—

Reactive arthropathies, FINNGEN

2.10

2.12

5.0

4.1

—

Other bursopathies

243

1.61

2.12

3.0

4.4

—

Cramp and spasm

2.37

2.12

3.2

3.9

—

Thyroiditis, ILD-related definition

130

1.85

2.12

5.5

4.2

—

Acute nasopharyngitis (common cold)

2.01

2.11

3.8

3.9

—

Multiple myeloma and malignant plasma cell neoplasms

2.06

2.11

3.9

3.8

—

Pustulosis palmaris et plantaris

2.46

2.10

2.7

4.1

—

Any dementia

794

0.73

2.10

3.0

3.7

—

Systemic sclerosis (FG)

3.22

2.10

3.6

4.4

—

Mumps

3.22

2.09

8.5

5.0

—

Other demyelinating diseases of the central nervous system

3.21

2.09

2.7

4.9

—

Fissure and fistula of anal and rectal regions

421

1.45

2.09

3.9

3.7

—

Degeneration of macula and posterior pole

154

971

1.26

2.09

4.2

3.6

—

Mesothelioma

5.05

2.07

1.6

5.9

—

Acquired stenosis of external ear canal

5.05

2.07

5.0

7.1

—

Unspecified threat to breathing

5.05

2.07

6.4

6.6

—

Myelodysplastic syndrome

5.05

2.07

3.4

5.5

—

Injury of nerves at shoulder and upper arm level

5.05

2.07

3.0

5.2

—

Contact with heat and hot substances

2.27

2.07

7.1

4.7

—

Malignant neoplasm of lip, including Hilmo

5.05

2.07

2.4

5.9

—

Colorectal neuroendocrine tumor and carcinoma

5.04

2.07

4.6

5.8

—

Isolated proteinuria

2.92

2.07

2.1

4.6

—

Migraine

483

1.38

2.06

4.4

4.1

—

Other peripheral vascular diseases

117

1.89

2.06

3.4

3.8

—

Nonalcoholic fatty liver disease

117

1.89

2.05

6.8

4.7

—

Varicose veins of other sites

2.03

2.05

3.4

4.2

—

Recurrent aphthous stomatitis , including avohilmo

222

1.62

2.05

3.4

4.7

—

Carcinoma in situ of cervix uteri

2.33

2.04

3.6

4.2

—

Hyperosmolality and hypernatraemia

4.03

2.04

2.5

3.5

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.18

2.04

3.6

5.3

—

Disorders of iron metabolism

4.03

2.04

3.5

3.0

—

Perioral dermatitis

4.02

2.04

3.8

6.1

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

316

1.51

2.03

3.0

4.0

—

Nonorganic sleeping disorders, excluding more controls

238

1.60

2.03

4.3

3.9

—

Hypertensive Renal Disease

2.12

2.02

3.2

3.6

—

Acute alcohol intoxication, ICD10

326

1.51

2.02

3.1

4.0

—

Drug-induced cataract

3.10

2.01

8.0

4.7

—

Malignant neoplasm of mesothelium and soft tissue

2.51

2.01

2.0

4.2

—

Alcohol abuse, main dg

231

1.60

2.01

2.9

4.2

—

Other vitreous opacities

2.23

2.01

2.8

3.7

—

Diabetic retinopathy, excluding more controls

243

1.46

2.01

3.2

4.1

—

Motor neuron disease

2.83

2.00

2.0

4.5

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

2.83

2.00

3.4

4.2

—

Malignant neoplasm of bladder, including Hilmo

261

1.56

2.00

3.1

4.0

—

SLE, strict definition

2.82

2.00

3.3

5.0

—

SLE, ICD10

2.82

2.00

3.3

5.0

—

Other and unspecified glaucoma

133

1.81

1.99

2.8

3.8

—

Recurrent dislocation and subluxation of joint

2.29

1.97

2.8

3.8

—

Anxiety (asthma-related co-morbidities)

113

671

1.30

1.97

4.6

4.1

—

Noninfectious colitis NAS

209

1.63

1.97

3.8

—

Allergic contact dermatitis due to drugs in contact with skin

3.35

1.97

10.3

5.2

—

Congenital malformations, deformations and chromosomal abnormalities

132

956

1.27

1.97

3.8

4.0

—

Burns and corrosions of multiple and unspecified body regions

3.35

1.97

3.1

4.8

—

Barrett oesophagus

2.09

1.96

3.3

3.5

—

Collagenous colitis

134

1.80

1.95

3.6

3.9

—

Tubulo-interstitial nephritis, not specified as acute or chronic

1.94

1.95

3.3

3.4

—

Ulcerative rectosigmoiditis

1.94

1.95

4.5

3.8

—

Gastrointestinal stromal tumor and sarcoma

4.59

1.94

4.0

5.3

—

Disorders of porphyrin and bilirubin metabolism

4.58

1.94

4.8

2.9

—

Malignant neoplasm of tonsil, including Hilmo

4.57

1.94

2.8

5.5

—

Benign neoplasm: Anus and anal canal

2.58

1.94

4.3

—

Other erythematous conditions

2.58

1.94

3.8

4.5

—

Systemic sclerosis, icd10

2.98

1.94

3.6

5.2

—

Acquired haemolytic anaemia

2.98

1.94

4.0

4.9

—

Systemic sclerosis

2.98

1.94

3.6

5.1

—

Certain zoonotic bacterial diseases

3.77

1.94

2.8

5.3

—

Hypermobility syndrome

2.97

1.93

2.9

4.3

—

Retinal haemorrhage

2.74

1.93

4.1

4.6

—

Dislocation, sprain and strain of joints and ligaments of thorax

2.74

1.93

4.9

4.2

—

Dislocation, sprain and strain of joints and ligaments of head

2.74

1.93

2.6

6.7

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

468

1.40

1.93

3.8

3.9

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

104

774

1.31

1.91

4.1

3.9

—

Acute posthaemorrhagic anaemia

2.25

1.91

4.8

4.0

—

Other secondary gonarthrosis

2.06

1.91

4.3

3.5

—

Calcific tendinitis of shoulder

2.06

1.91

5.4

5.1

—

Exclusions for E4_PCOS_CONSORTIUM

142

704

1.26

1.90

4.0

4.1

—

Type 1 diabetes, wide definition, subgroup 1

266

1.54

1.90

5.7

3.9

—

Cysts of oral region, not elsewhere classified

2.01

1.90

3.4

4.4

—

Malignant neoplasm of prostate, including Hilmo

408

1.34

1.89

3.2

3.9

—

Malignant cancer of tonsil and base of tongue, including Hilmo

3.20

1.88

3.0

4.5

—

Polyneuropathies and other disorders of the peripheral nervous system

473

1.40

1.88

4.5

3.8

—

Hypertrophic cardiomyopathy

2.16

1.88

5.0

4.3

—

Alopecia areata

3.20

1.88

4.4

5.5

—

Other acquired deformities of musculoskeletal system and connective tissue

2.32

1.87

4.3

5.1

—

Caries of enamel

133

1206

0.79

1.87

3.6

4.0

—

Malignant neoplasm of oesophagus

2.87

1.86

3.8

3.9

—

Hidradenitis suppurativa

2.87

1.86

3.6

4.6

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

2.40

1.85

2.9

5.0

—

Cluster headache, wide,, including avohilmo

2.40

1.85

4.2

4.7

—

Fall on same level involving ice and snow

139

1111

1.25

1.85

4.2

3.9

—

Malignant neoplasm of vulva, including Hilmo

3.56

1.84

4.3

4.8

—

Isolated proteinuria with specified morphological lesion

4.20

1.83

3.0

6.8

—

Colitis, primary sclerosing

4.20

1.82

3.8

4.3

—

Malignant neoplasm of rectosigmoid junction

4.19

1.82

3.2

5.0

—

Scabies

137

1.75

1.82

3.6

4.4

—

Routine general health check-up of defined subpopulation

4.18

1.82

6.6

4.1

—

Coxarthrosis, primary, with hip surgery

146

1100

1.24

1.81

3.5

3.8

—

Migraine with aura and triptan purchases

130

1.77

1.81

5.0

4.4

—

Other disorders of the musculoskeletal system and connective tissue

270

1.52

1.81

3.1

4.0

—

Follicular lymphoma, hilmo

2.07

1.80

3.7

4.7

—

Cholangitis (primary sclerosing, PSC)

101

1.89

1.80

3.4

4.0

—

Achalasia of cardia

3.06

1.80

2.7

5.0

—

Other specified disorders of muscle

2.58

1.80

8.7

5.1

—

Maternal care for cervical incompetence

2.58

1.80

3.0

4.9

—

Olecranon bursitis

123

1.80

4.0

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

123

1.79

3.5

3.9

—

Amyloidosis

2.78

1.79

7.4

3.2

—

Other articular cartilage disorders

2.77

1.79

2.9

3.2

—

Golimumab

2.77

1.79

3.0

4.4

—

Mucosal proctocolitis

153

1.70

1.79

6.0

3.6

—

Fracture of forearm

128

931

1.26

1.79

4.5

3.9

—

Monoamine oxidase A inhibitors

176

1.65

1.79

4.0

4.1

—

Inflammatory diseases of prostate (prostatitis)

271

1.52

1.78

3.2

3.6

—

Postprocedural disorders of nervous system

2.35

1.77

2.8

5.4

—

Chronic gastritis

581

1.34

1.77

4.1

3.7

—

Diseases of male genital organs

145

584

1.25

1.77

3.8

3.6

—

Foreign body in alimentary tract

2.03

1.75

4.1

4.8

—

Enteropathic arthropathies

3.35

1.75

2.7

3.5

—

Diseases of inner ear

145

1134

1.24

1.75

4.4

3.8

—

Oligomenorrhoea

3.34

1.74

2.8

3.3

—

Systemic lupus erythematosus

2.51

1.74

3.3

4.9

—

Anti-inflammatory and antirheumatic products, non-steroids

314

1.35

1.73

3.7

3.9

—

Injury of muscle and tendon at shoulder and upper arm level

740

1.30

1.73

3.4

3.8

—

Mixed conductive and sensorineural hearing loss

225

1.56

1.73

5.8

3.8

—

Erythema nodosum

2.68

1.72

3.5

4.8

—

Other surgical follow-up care

2.68

1.72

2.4

4.5

—

Primary gonarthrosis, bilateral

150

1043

1.23

1.72

4.3

3.8

—

Optic neuritis

2.67

1.72

10.3

4.7

—

Other bursitis of elbow

3.89

1.72

2.6

5.0

—

Open wound of ankle and foot

155

1.68

1.72

3.4

4.3

—

Other disorders of optic disc

3.87

1.72

10.2

6.9

—

Senility

3.86

1.71

6.4

3.5

—

Disorders of refraction and accommodation

371

1.42

1.71

4.2

4.0

—

Macular cyst

0.00

1.70

0.0

3.9

—

Renal cell carcinoma of kidney

2.30

1.70

3.5

3.7

—

Restless leg syndrome

218

1.56

1.70

4.7

4.2

—

Diseases of external ear

655

1.31

1.69

4.3

3.7

—

Other disorders of optic [2nd] nerve and visual pathways

2.01

1.69

8.7

4.9

—

Fracture of foot, except ankle

340

1.44

1.69

3.5

4.1

—

Persons encountering health services in circumstances related to reproduction

611

0.74

1.68

6.0

4.0

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

187

1.61

1.68

5.9

4.0

—

Convalescence

2.19

1.67

3.7

—

Benign neoplasm of bone and articular cartilage

104

1.83

1.67

3.6

5.3

—

CR(E)ST syndrome

3.18

1.66

4.2

5.5

—

Anomalies of pupillary function

3.17

1.66

5.2

5.9

—

Mental and behavioural disorders due to cannabinoids

3.17

1.66

3.0

4.3

—

Hyperhidrosis

3.17

1.66

5.8

3.4

—

Juvenile arthritis (FINNGEN)

2.59

1.66

2.0

7.3

—

Carcinoma in situ of skin

188

1.60

1.65

3.5

3.7

—

Other benign neoplasm of uterus: Other parts/unspecified

2.11

1.65

2.8

4.4

—

Other symptoms and signs involving general sensations and perceptions

2.11

1.65

6.0

4.3

—

Orchitis and epididymitis

188

1.60

1.65

3.1

3.9

—

Malignant neoplasm of tongue, including Hilmo

2.81

1.65

2.7

4.4

—

All anxiety disorders

114

712

1.27

1.65

4.6

4.0

—

Dementia, including avohilmo

105

916

0.79

1.65

3.0

3.7

—

Lesion of sciatic nerve

1.94

1.64

4.4

3.5

—

Sequelae of other external causes

1.98

1.64

6.5

3.8

—

Anogenital herpesviral [herpes simplex] infection

2.44

1.64

3.2

4.8

—

Otitis externa

376

1.41

1.64

3.4

3.9

—

Disorders resulting from impaired renal tubular function

2.26

1.63

4.2

4.1

—

Contraceptive management

403

0.68

1.62

6.1

4.2

—

Exophthalmic conditions

3.60

1.62

1.8

5.8

—

Abnormal findings on diagnostic imaging of breast

3.59

1.62

2.6

6.4

—

Benign neoplasm: Other/unspecified site

3.59

1.62

3.6

5.6

—

Other disorders of eye and adnexa

205

1.56

1.62

3.5

4.7

—

Other contact dermatitis

1.84

1.61

3.3

4.0

—

Right bundle-branch block

2.15

1.61

4.8

3.6

—

Bullous disorders

1.87

1.60

3.9

3.7

—

Other and unspecified nerve root and plexus disorders, also in other diseases

311

1.45

1.60

3.4

3.7

—

Other and unspecified polyneuropathies, also in other diseases

420

1.38

1.60

4.7

3.8

—

Carcinoma in situ of skin of ear and external auricular canal

2.52

1.60

3.1

3.3

—

Loose body in joint

2.51

1.60

4.8

3.2

—

Other and unspecified diseases of blood and blood-forming organs

2.51

1.60

3.3

3.9

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

2.51

1.60

2.8

3.8

—

Multiple myeloma

2.51

1.60

2.8

3.8

—

Oesophageal varices

2.07

1.60

2.8

4.0

—

Glaucoma secondary to other eye disorders

2.07

1.60

2.8

3.7

—

Septal defects

2.14

1.59

3.2

6.3

—

Other specified/unspecified soft tissue disorders

2.01

1.59

3.3

4.4

—

Trigeminal neuralgia

2.01

1.59

3.6

3.9

—

Foreign body on external eye

222

1.53

1.59

3.5

4.0

—

Benign neoplasm: Larynx

2.34

1.59

3.4

4.0

—

Ulcerative ileocolitis

2.33

1.59

7.5

4.7

—

Left bundle-branch block

106

1.80

1.58

3.2

3.9

—

Cardiomyopathy, Hypertrophic obstructive

3.02

1.58

5.8

3.9

—

Algoneurodystrophy

2.70

1.58

5.6

3.2

—

Total colectomy operation

2.21

1.57

6.0

4.5

—

Total colectomy

2.21

1.57

6.0

4.5

—

Perforation of tympanic membrane

152

1.65

1.56

3.5

4.2

—

Trochanteric bursitis

207

1.55

1.56

5.5

4.4

—

Other secondary coxarthrosis

2.28

1.55

6.5

4.2

—

Cervicobrachial syndrome

330

1.43

1.55

4.0

—

Tongue abnormality

1.89

1.55

2.8

4.4

—

Myalgia

347

1.41

1.54

3.2

4.2

—

Decubitus ulcer and pressure area

122

1.73

1.54

3.0

3.2

—

Acetic acid derivatives and related substances

309

1.33

1.54

3.9

3.6

—

Neovascular glaucoma

2.04

1.54

2.8

3.9

—

Benign neoplasm of male genital organs

2.44

1.54

2.8

2.9

—

Small fibre neuropathy

2.43

1.54

2.5

4.4

—

Other and unspecified mononeuropathies of lower limb

2.43

1.54

3.4

4.1

—

Malignant neoplasm of stomach, including Hilmo

100

1.81

1.53

4.7

4.2

—

Disorders of vestibular function (Vertigo)

123

979

1.24

1.52

4.7

3.7

—

Autonomic disorders

2.60

1.51

3.6

5.1

—

Other congenital malformations of circulatory system

2.60

1.51

7.9

4.7

—

Post-traumatic wound infection, not elsewhere classified

2.60

1.51

3.1

4.5

—

Symptoms and signs involving emotional state

2.60

1.51

6.6

6.2

—

Psoriatic arthropathies

138

1.67

1.51

3.5

4.1

—

Acute alcohol intoxication

485

1.34

1.51

3.0

4.0

—

Perichondritis of external ear

2.87

1.51

4.8

5.4

—

Lateral epicondylitis

185

1.57

1.51

3.2

4.4

—

Chondropathies

209

1.53

1.50

2.6

4.4

—

Polycystic ovarian syndrome

2.86

1.50

4.2

4.0

—

Functional dyspepsia

451

1.35

1.50

4.9

3.8

—

Alzheimer’s disease (Late onset), excluding more controls

244

0.62

1.50

2.7

3.8

—

Systemic atrophies primarily affecting the central nervous system

2.01

1.48

2.3

4.0

—

Statin medication

157

729

1.21

1.48

4.5

3.8

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

300

1.44

1.48

2.9

4.0

—

Superficial injury of ankle and foot

116

1.73

1.48

3.4

5.0

—

Other predominantly sexually transmitted diseases, not elsewhere classified

139

1.66

1.48

3.9

4.4

—

Striking against or struck by other objects

521

1.32

1.47

3.3

3.8

—

Injuries to the wrist and hand

242

1443

1.16

1.47

3.8

—

Myelodysplastic syndrome, including Hilmo

2.23

1.46

3.4

3.9

—

Hereditary corneal dystrophies

2.23

1.46

8.2

5.2

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

2.23

1.46

3.9

4.4

—

Neuromuscular dysfunction of bladder

155

1.62

1.46

3.0

3.8

—

Dementia

848

0.79

1.46

3.0

3.8

—

Other and unspecified mood [affective] disorders

2.23

1.46

3.1

7.2

—

Intermittent heterotropia

2.22

1.46

3.2

6.5

—

Testicular hypofunction

2.38

1.45

3.8

4.4

—

Injury of nerves at wrist and hand level

2.38

1.45

2.0

5.2

—

Other specified/unspecified inflammatory spondylopathies

2.37

1.45

2.9

4.4

—

Retinal breaks without detachment

293

1.44

1.45

4.3

3.9

—

Type 1 diabetes, wide definition

301

1.43

1.45

5.7

3.8

—

Urolithiasis

734

1.27

1.45

3.6

3.8

—

Wet age-related macular degeneration

407

1.36

1.45

3.5

3.6

—

Open wound of wrist and hand

100

778

1.26

1.44

3.7

—

Redundant prepuce, phimosis and paraphimosis

357

1.39

1.44

3.5

3.4

—

Portal vein thrombosis

3.14

1.44

3.2

4.3

—

Secondary malignant neoplasm of respiratory and digestive organs

3.14

1.44

2.6

4.6

—

Malignant neoplasm of tongue

3.14

1.44

2.6

4.4

—

Burn and corrosion of head and neck

3.14

1.44

3.4

8.5

—

Urethritis and urethral syndrome

2.74

1.43

2.2

3.7

—

Congenital malformations of cardiac septa

2.04

1.43

3.2

6.2

—

Bacterial meningitis

2.32

1.43

2.7

5.1

—

Other specified/unspecified bacterial intestinal infections

1.79

1.43

3.6

3.5

—

Suicide or other Intentional self-harm

336

1.40

1.42

3.0

4.1

—

Other mental disorders due to brain damage and dysfunction and to physical disease

253

1.47

1.42

3.2

3.9

—

Postmenopausal atrophic vaginitis

229

1.37

1.42

3.5

4.1

—

Postprocedural musculoskeletal disorders, not elsewhere classified

118

1.70

1.41

3.2

4.5

—

Faecal incontinence

126

1.67

1.39

3.9

4.4

—

Other and unspecified acute skin changes due to ultraviolet radiation

2.42

1.39

3.9

4.1

—

Spirochaetal infections, other/unspecified

139

0.43

1.39

3.0

4.4

—

Benign neoplasm: Choroid

1.78

1.39

8.6

4.0

—

Fracture of skull and facial bones

338

1.39

3.0

4.1

—

Other/unspecified enthesopathies of lower limb, excluding foot

1.90

1.39

3.9

4.3

—

Salpingitis and oophoritis

230

1.48

1.38

4.0

4.3

—

Other and unspecified abdominal hernia

2.01

1.38

3.1

3.7

—

Crohn disease (strict definition, require KELA)

2.00

1.38

3.1

4.7

—

Carcinoma in situ of skin of upper limb, including shoulder

2.21

1.37

2.9

4.2

—

Normotensive glaucoma

182

1.54

1.37

3.9

4.0

—

Other and unspecified nail disorders

2.62

1.37

2.8

5.3

—

Benign neoplasm of eye and adnexa

182

1.54

1.37

6.4

4.2

—

Other and unspecified urticaria

272

1.44

1.36

3.7

4.2

—

Chronic myeloproliferative disease

2.96

1.36

2.6

5.9

—

Inflammation of lacrimal passages (acute and unspecified)

2.95

1.36

3.8

6.3

—

Cerebral atherosclerosis

2.95

1.35

4.2

5.6

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

495

1.31

1.34

4.2

3.9

—

Glucagon-like peptide-1 (GLP-1) analogues

495

1.31

1.34

4.2

3.9

—

Calculus of kidney and ureter

671

1.27

1.34

3.7

—

Migraine with aura

248

1.45

1.34

4.4

—

Other sexually transmitted chlamydial diseases

0.00

1.34

0.0

4.7

—

Anogenital herpesviral [herpes simplex] infection

1.87

1.34

3.4

4.3

—

Malignant neoplasm of oesophagus, including Hilmo

2.14

1.34

3.4

3.6

—

Sequelae of other and unspecified infectious and parasitic diseases

2.04

1.32

6.2

3.7

—

Other ulcerative colitis

1.97

1.32

5.3

4.3

—

Transport accidents

654

1.25

1.32

3.7

3.9

—

Nonorganic sleeping disorders

266

1.43

1.31

4.3

4.1

—

Arthropathic psoriasis

160

1.57

1.31

3.7

3.8

—

Other conjunctival vascular disorders and cysts

2.51

1.30

3.3

5.1

—

Dentofacial anomalies [including malocclusion]

129

857

1.21

1.30

4.5

3.8

—

Other aneurysm

106

1.70

1.29

3.3

3.4

—

Adenocarcinoma and papillary adenocarcinoma of stomach

2.36

1.29

4.3

4.0

—

Benign neoplasm of thyroid gland

2.36

1.29

3.4

4.6

—

Other and unspecified corneal deformities and disorders

2.36

1.29

5.1

4.5

—

Helminthiases

2.36

1.29

2.4

5.1

—

Benign neoplasm: Short bones of upper limb

2.79

1.28

2.4

5.2

—

Benign neoplasm: Skin of upper limb, including shoulder

2.79

1.28

2.8

5.6

—

Contusion of toe(s) without damage to nail

2.79

1.28

2.4

5.2

—

Allergic conjunctivitis

105

833

1.23

1.27

4.1

3.9

—

Chronic periodontitis, complicated

140

1163

1.19

1.27

3.5

3.9

—

Pemphigoid

2.05

1.27

4.7

4.2

—

Burn and corrosion of trunk

2.29

1.27

2.8

5.9

—

Malignant neoplasm of stomach

1.79

1.27

5.2

4.2

—

Chronic hepatitis, not elsewhere classified

2.29

1.27

8.3

4.6

—

Testicular dysfunction

2.05

1.27

3.8

4.3

—

Continuous positive airway pressure

204

1.45

1.26

3.1

3.6

—

Coxarthrosis, primary

175

1265

1.17

1.26

3.3

3.8

—

Other benign neoplasms of uterus

1.82

1.25

3.4

4.4

—

Other predominantly sexually transmitted diseases, not elsewhere classified

162

1.54

1.25

3.8

4.5

—

Amyloidosis, other/unspecified

2.41

1.24

2.8

3.2

—

Cutaneous lupus erythematosus

2.41

1.24

3.2

4.2

—

Sequelae of injuries of lower limb

115

1.66

1.24

2.8

4.1

—

Other juvenile arthritis

2.40

1.24

1.8

6.2

—

Chronic mastoiditis

2.23

1.24

3.3

4.5

—

Benign neoplasm: other/unspecified salivary gland

2.23

1.24

4.4

4.5

—

Idiopathic thrombocytopenic purpura

2.23

1.24

2.8

4.5

—

Muscle strain

2.23

1.24

6.7

4.8

—

Somnolence, stupor and coma

1.86

1.24

2.8

4.0

—

Malignant neoplasm of digestive organs

619

1.24

1.23

3.8

4.0

—

Benign neoplasm: Other and unspecified parts of mouth

2.01

1.23

3.0

4.2

—

Radial styloid tenosynovitis [de Quervain]

2.00

1.23

3.1

5.9

—

Pruritus

163

1.54

1.22

3.8

4.4

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

1.91

1.22

3.1

4.6

—

Disorders of vitreous body and globe

133

1070

1.19

1.22

3.9

3.8

—

Other extrapyramidal and movement disorders in other diseases

468

1.31

1.22

4.0

3.8

—

Disorders of vitreous body

129

1041

1.20

1.22

4.0

3.8

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

1.97

1.22

5.1

4.9

—

Infectious mononucleosis

2.04

1.22

2.7

5.6

—

Iridocyclitis in diseases classified elsewhere

2.64

1.22

3.2

5.7

—

Chronic Coagulation defects

2.64

1.21

3.4

5.2

—

Hypertrophy of breast

204

1.47

1.21

4.2

—

Postprocedural disorders of digestive system, not elsewhere classified

2.17

1.21

5.5

3.8

—

Gonarthrosis,primary

247

1334

1.14

1.20

3.9

3.7

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

1.83

1.19

2.8

3.8

—

Periapical abscess

100

818

1.22

1.19

3.8

4.0

—

Secondary polycythaemia

2.32

1.19

2.8

4.0

—

Arterial embolism and thrombosis

109

1.65

1.18

4.9

3.4

—

Benign neoplasm: Rectosigmoid junction

1.88

1.18

3.7

3.8

—

Dislocation, sprain and strain of joints and ligaments of elbow

1.93

1.17

2.9

6.8

—

Atopic dermatitis

102

685

1.22

1.16

4.6

3.9

—

Ovarian cyst

259

1.31

1.16

4.4

4.0

—

Effects of foreign body entering through natural orifice

411

1.32

1.16

3.5

4.1

—

Other specified/unspecified spondylopathies

2.06

1.15

2.4

3.6

—

Other diseases of spinal cord

2.06

1.15

4.5

4.4

—

Other acute skin changes due to ultraviolet radiation

2.06

1.15

7.7

4.1

—

Hyperprolactinaemia

2.51

1.15

2.8

4.7

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

110

1.64

1.15

4.3

4.5

—

Diabetic nephropathy

338

1.35

1.14

3.0

3.8

—

Corns and callosities

1.69

1.13

2.7

4.2

—

Examination and observation for other reasons

124

599

1.20

1.12

4.2

3.6

—

Other superficial mycoses

103

1.65

1.12

3.9

4.6

—

Ingrowing nail

1.90

1.12

4.1

5.0

—

Covid-19 suspected case

284

1.37

1.12

3.4

4.2

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

119

1.60

1.11

2.8

3.8

—

Panic disorder

119

1.60

1.11

4.5

4.3

—

Crohn's disease of large intestine

1.97

1.11

2.6

5.0

—

Congenital malformations of the circulatory system

178

1.47

1.11

4.5

4.6

—

Malignant neoplasm of oral cavity, including Hilmo

1.97

1.11

3.0

4.2

—

Seborrhoeic keratosis

459

1.29

1.09

3.3

3.8

—

Coronary artery bypass grafting

446

1.25

1.09

3.3

3.5

—

Third [oculomotor] nerve palsy

2.39

1.09

2.0

5.5

—

Erosion and ectropion of cervix uteri

2.39

1.09

2.8

5.0

—

Supervision of normal pregnancy

105

0.54

1.09

2.3

4.5

—

Hemiplegia

1.82

1.09

2.1

4.2

—

Bicuspidal aortic valve syndrome

1.96

1.09

2.6

5.2

—

Unspecified/other endometriosis

1.82

1.09

2.5

3.7

—

Type 1 diabetes, strict definition, subgroup 1

1.95

1.08

3.3

3.5

—

Lichen sclerosus et atrophicus

144

1.53

1.08

7.1

4.3

—

Other psoriatic arthropathies

136

1.55

1.08

3.8

4.3

—

Bursitis of shoulder

2.20

1.08

6.4

3.9

—

Other congenital malformations

128

1.56

1.08

3.5

5.0

—

Poor fetal growth

1.87

1.07

3.6

3.5

—

Demyelinating diseases of the central nervous system

1.76

1.06

2.7

4.6

—

Polycystic ovarian syndrome, broad definition

1.92

1.06

4.2

3.5

—

Other bullous disorders

2.13

1.05

3.3

4.3

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

2.12

1.05

4.6

4.3

—

Tinnitus

418

1.29

1.05

6.1

3.7

—

Malignant neoplasm of bladder

129

1.55

1.05

3.6

3.7

—

Superficial injury of shoulder and upper arm

178

1.46

1.05

3.5

4.4

—

Antenatal screening

109

0.57

1.05

2.5

4.7

—

Pyoderma

2.28

1.03

6.8

5.2

—

Malignant neoplasm of other connective and soft tissue

2.28

1.03

2.6

4.3

—

Burn and corrosion confined to eye and adnexa

2.28

1.03

3.6

4.8

—

Congenital ovarian cysts

2.28

1.03

4.4

4.1

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

148

0.54

1.03

2.6

3.8

—

Diaphragmatic hernia

760

1.21

1.03

4.2

3.6

—

Memory loss

203

0.59

1.03

8.4

3.8

—

Myeloid leukaemia

2.07

1.03

2.3

4.4

—

Malignant neoplasm of oral cavity

2.06

1.03

3.0

3.9

—

Impetigo

2.06

1.03

3.9

7.2

—

Hydronephrosis

204

1.42

1.02

3.7

4.0

—

Artificial joint re-operation

122

1.56

1.02

3.4

4.0

—

Paralytic strabismus

122

1.56

1.02

2.7

3.5

—

Crowding of teeth, including avohilmo

1.91

1.01

7.0

6.4

—

Fall involving bed

1.89

1.01

3.0

4.0

—

Pericarditis

1.89

1.01

3.4

3.6

—

Obstructed labour due to malposition and malpresentation of fetus

144

1.49

1.01

4.7

4.1

—

Intestinal adhesions without obstruction

155

1.49

1.01

4.0

4.2

—

Infections with a predominantly sexual mode of transmission

333

1.32

1.00

3.5

4.0

—

Amiodarone users

222

1.40

1.00

3.4

3.8

—

Other/unspecified synovitis and tenosynovitis

180

1.45

1.00

4.9

4.6

—

Sequelae of injuries of neck and trunk

2.01

1.00

5.7

4.1

—

Abscess of anal and rectal regions

115

1.57

0.99

2.7

4.5

—

Crossbite

1.85

0.99

9.9

4.3

—

Status epilepticus

1.84

0.98

2.8

4.8

—

Intestinal malabsorption

1.84

0.98

3.0

4.6

—

Motorcycle rider injured in other and unspecified transport accidents

1.81

0.98

3.4

6.2

—

Disorders of optic nerve, not elsewhere classified

2.18

0.98

6.8

5.1

—

Exposure to smoke, fire and flames

2.18

0.98

3.0

4.5

—

Migraine without aura

156

1.48

0.98

5.7

5.1

—

1.71

0.98

3.2

3.6

—

Foreign body or object entering through skin

1.67

0.97

2.9

5.3

—

Carpal tunnel syndrome

140

1063

1.16

0.97

3.6

3.8

—

Central retinal artery occlusion

1.95

0.97

2.7

4.5

—

Gingival hyperplasia

1.95

0.97

3.1

5.0

—

Adenomyosis (Endometriosis of uterus)

173

1.45

0.97

4.4

4.2

—

Ovarian dysfunction

1.95

0.97

4.0

3.7

—

Myocardial infarction, unclassifiable

529

1.23

0.97

3.7

3.5

—

Other shoulder lesions

132

1.52

0.97

3.1

4.4

—

Carcinoma in situ of other and unspecified sites

1.75

0.96

3.1

3.6

—

Coeliac disease

157

1.47

0.95

4.3

4.6

—

Circumscribed brain atrophy

0.00

0.95

0.0

4.4

—

Dislocation, sprain and strain of joint and ligaments of hip

1.77

0.94

2.7

4.0

—

Hepatic failure, not elsewhere classified

1.77

0.94

2.3

4.5

—

Twin gestation

1.77

0.94

4.4

3.8

—

Disorders of speech understanding and production

2.27

0.94

4.5

8.5

—

Gluteal tendinitis

1.90

0.94

4.0

4.1

—

Parkinson's disease, strict definition

340

0.70

0.93

2.8

3.7

—

Fourth [trochlear] nerve palsy

2.23

0.93

2.5

5.0

—

Paraplegia, diplegia of upper limbs

2.23

0.93

2.8

4.9

—

Other congenital malformations of the digestive system

1.88

0.93

2.7

7.0

—

Atypical facial pain

1.73

0.92

4.3

5.0

—

Post-traumatic stress disorder

1.73

0.92

4.4

6.2

—

Other diseases of peritoneum

1.82

0.92

3.5

4.3

—

MS-disease / Multiple Sclerosis

1.82

0.92

2.7

4.5

—

Other enthesopathy of foot (+metatarsalgia)

142

1.48

0.92

3.4

4.7

—

Multiple gestation

1.82

0.92

4.8

4.4

—

Any dementia, excluding more controls

680

0.83

0.92

3.0

3.7

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

374

1.28

0.92

3.0

4.0

—

Burns and corrosions confined to eye and internal organs

2.15

0.91

3.5

5.7

—

Enthesopathies of lower limb, excluding foot

339

1.30

0.91

3.7

4.1

—

Ascites

126

1.51

0.91

2.7

4.6

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

298

1.24

0.90

3.8

3.6

—

Psoriatic arthropathies, ICD10

143

1.47

0.89

3.8

4.2

—

Misadventures to patients during surgical and medical care

245

1.35

0.88

3.8

3.9

—

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

1.91

0.88

2.9

4.2

—

Other and unspecified intracranial injuries

1.91

0.88

6.1

4.1

—

Congenital malformations and deformations of the musculoskeletal system

1.74

0.88

4.3

6.0

—

Colectomy operation

350

1.29

0.88

5.1

3.7

—

Colonic or urogenital fistula

520

1.23

0.88

3.8

—

Herpesviral keratitis and keratoconjunctivitis

1.79

0.88

3.5

3.9

—

Triptan medication for migraine, single purchase ok

136

798

1.15

0.87

4.4

4.0

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

136

798

1.15

0.87

4.4

4.0

—

Other diseases of stomach and duodenum

103

1.56

0.87

4.0

—

Benign neoplasm: Conjunctiva

1.87

0.87

3.0

4.1

—

Arthropathies in other diseases classified elsewhere

1.87

0.87

6.5

3.0

—

Hypertrophy of breast in women and men

263

1.33

0.87

4.2

4.0

—

Other and unspecified injuries of head

1.58

0.87

3.1

4.2

—

Other crystal arthropathies

2.01

0.87

1.8

3.3

—

Left hemicolectomy

2.01

0.87

8.3

4.7

—

Benign paroxysmal vertigo

584

1.22

0.87

5.1

3.7

—

Other and specified injuries of hip and thigh

2.01

0.87

3.7

5.5

—

Ulcerative enterocolitis

2.00

0.87

4.8

4.4

—

Pediculosis, acariasis and other infestations

186

1.40

0.87

3.5

4.5

—

Melanocytic naevi of other and unspecified parts of face

1.72

0.86

2.4

4.6

—

Long labour

165

0.62

0.86

5.8

4.3

—

Contusion of other and unspecified parts of foot

1.82

0.86

2.9

6.7

—

Hallux rigidus

240

0.67

0.85

3.4

4.1

—

Type 1 diabetes, strict definition

1.82

0.85

3.3

3.6

—

Burns and corrosions

187

1.39

0.84

5.5

4.2

—

Vestibular neuronitis

145

1.45

0.84

3.9

4.0

—

Haemorrhage in early pregnancy

300

1.30

0.84

3.6

4.4

—

Intrahepatic Cholestasis of Pregnancy (ICP)

1.94

0.84

5.3

3.9

—

Temporomandibular joint disorders, including avohilmo

569

1.21

0.84

4.2

4.1

—

Atrial septal defect

1.93

0.84

2.7

7.6

—

Postpartum hemorraghe, all women as controls

176

1.40

0.84

4.8

4.0

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

1.76

0.83

4.3

3.7

—

Sudden idiopathic hearing loss

171

1.41

0.83

3.7

3.9

—

Monoarthritis, not elsewhere classified

1.74

0.82

2.9

3.2

—

Inflammatory disorders of breast

1.74

0.82

6.6

4.5

—

Pedal cyclist injured in noncollision transport accidents

146

1.44

0.82

3.6

4.7

—

Other disorders of the genitourinary system

214

1.36

0.82

5.2

4.0

—

Crystal arthropathies, rheuma endpoint

1.88

0.82

1.8

3.8

—

Oral lichen planus

1.88

0.82

2.3

5.2

—

Open wound of hip and thigh

1.88

0.82

2.5

5.3

—

Dislocation, sprain and strain of joints and ligaments at neck level

163

1.41

0.81

5.7

4.6

—

Malignant neoplasm, without specification of site, including Hilmo

1.65

0.81

4.2

3.7

—

Unspecified lump in breast

206

1.36

0.81

4.3

4.1

—

Other and unspecified local infections of skin and subcutaneous tissue

155

1.42

0.81

5.3

4.0

—

Dronedarone medication

1.71

0.80

3.0

3.9

—

Visual field defects

147

1.43

0.80

9.2

3.9

—

Localized swelling, mass and lump of skin and subcutaneous tissue

609

1.20

0.79

3.7

3.8

—

L02BB Anti-androgens

259

0.69

0.79

2.7

3.2

—

Visual impairment including blindness (binocular or monocular)

114

1.49

0.79

3.5

4.0

—

Malignant neoplasm of brain

0.00

0.79

0.0

5.5

—

Malignant neoplasm of rectosigmoid junction, including Hilmo

1.82

0.79

3.2

3.9

—

Superficial injury of wrist and hand

268

1.31

0.79

4.1

4.2

—

Sixth [abducent] nerve palsy

1.67

0.78

3.3

3.9

—

Persistent delusional disorders

106

1.51

0.78

3.1

4.2

—

Dermatophytosis

136

1193

1.14

0.78

3.8

—

Delivery, wide proxy

272

0.78

4.6

3.7

—

Spinal enthesopathy

1.67

0.78

2.0

3.6

—

Metatarsalgia

131

1.45

0.78

2.9

4.6

—

Unspecified jaundice

1.56

0.78

2.9

4.8

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

350

0.74

0.78

5.5

4.1

—

Diseases of appendix

163

1305

1.13

0.78

3.8

3.9

—

Other congenital malformations of the digestive system

1.66

0.78

2.8

6.1

—

Benign lipomatous neoplasm

565

1.20

0.78

3.5

3.8

—

Carcinoma in situ of breast, intraductal

123

0.57

0.77

2.7

4.6

—

Other problems related to primary support group, including family circumstances

1.62

0.77

4.2

6.0

—

Parkinson's disease

361

0.75

0.77

2.7

3.8

—

Inflammatory diseases of the central nervous system

115

1.48

0.76

2.5

4.2

—

Prurigo nodularis

1.77

0.76

5.0

4.7

—

Certain zoonotic bacterial diseases

1.77

0.76

2.8

4.5

—

Viral meningitis

1.77

0.76

3.8

5.4

—

All dysplastic lesions of the vulva

1.77

0.76

4.3

5.1

—

Propionic acid derivatives

314

1.20

0.76

3.4

3.9

—

Contact with nonpowered hand tool

1.70

0.76

3.4

4.8

—

Arterial embolism and thrombosis of lower extremity artery

1.65

0.75

3.4

—

Viral infections of the central nervous system

1.54

0.75

2.9

4.6

—

Erectile dysfunction

192

1.36

0.75

3.5

3.2

—

Viral infections of the central nervous system

1.57

0.75

2.9

4.3

—

Other/unspecified reactive arthropathies

1.60

0.75

6.2

4.3

—

Other congenital malformations of skin

1.60

0.74

3.6

6.0

—

Early lumbar disc prolapse, operated

1.60

0.74

4.8

3.6

—

Other renal tubulo-interstitial diseases

2.09

0.74

3.6

5.5

—

Ulcer of vagina/vulva

2.09

0.74

3.2

4.4

—

Superficial injuries involving multiple body regions

2.09

0.74

3.4

4.7

—

Cyst of Bartholin Gland

2.09

0.74

3.8

4.1

—

Spontaneous rupture of synovium and tendon

141

1.42

0.74

3.4

4.7

—

Other appendicitis

116

1.47

0.74

2.4

4.3

—

Diabetic retinopathy

467

1.18

0.73

3.1

3.9

—

Benign neoplasm of other and unspecified sites

1.85

0.73

4.3

4.5

—

Other disorders of male genital organs

1.64

0.73

3.1

5.2

—

Impotence

108

1.49

0.73

3.3

3.5

—

Pulmonary oedema

2.01

0.72

3.8

5.0

—

Erythema intertrigo

2.01

0.72

2.8

5.0

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

2.01

0.72

3.8

4.7

—

Other specified/unspecified dorsopathies

1.80

0.72

2.3

4.4

—

Glaucoma-related operations

107

0.56

0.72

3.8

—

195

0.67

0.72

2.8

3.6

—

Acne

1.61

0.72

2.4

6.2

—

Crohn disease (strict definition, require KELA, min 2 HDR)

1.67

0.72

3.2

4.7

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

1.62

0.71

3.1

4.5

—

Primary angle-closure glaucoma

1.58

0.71

3.8

4.1

—

Thyroiditis

1.62

0.71

5.4

4.6

—

Retinal detachments and breaks

802

1.16

0.71

3.7

—

Macular pucker

344

1.25

0.71

4.0

3.5

—

UC patients in KELA-register (code 208), prior to 1994

1.58

0.71

5.4

4.4

—

Acute lymphadenitis

1.58

0.71

2.3

5.9

—

Childhood allergy (age < 16)

1.58

0.71

12.0

3.6

—

Malignant neoplasm of corpus uteri

109

1.47

0.70

2.9

4.9

—

Injury of nerves and spinal cord at neck level

1.93

0.70

3.2

4.9

—

Viral agents as the cause of diseases classified to other chapters

1.93

0.70

5.2

4.7

—

Periodontal disease, other/unspecified

1.93

0.70

4.0

4.1

—

Other encephalitis

1.93

0.70

2.6

4.8

—

Other symptoms and signs involving cognitive functions and awareness

120

960

1.14

0.70

3.7

—

Synovial cyst of popliteal space [Baker]

126

1.43

0.70

3.5

4.9

—

Primary hyperparathyroidism

186

1.35

0.69

3.3

4.1

—

Other benign neoplasms of skin

776

1.16

0.69

3.4

3.6

—

Meningitis

1.55

0.69

2.7

4.8

—

Embedded teeth, including avohilmo

1.55

0.69

4.6

6.3

—

Postpartum hemorraghe, parous women as controls

158

1.35

0.69

4.8

4.3

—

Specific development disorders of speech and language

1.69

0.69

4.7

6.5

—

Atrophic disorders of skin

204

1.32

0.68

7.2

4.1

—

Other specific arthropathies, wide

1.86

0.68

2.6

4.3

—

Disorders of lacrimal system and orbit in diseases classified elsewhere

1.86

0.68

3.2

5.2

—

Benign neoplasm: Skin of lower limb, including hip

1.86

0.68

9.2

4.7

—

Encephalitis

1.86

0.68

2.6

4.9

—

Lichen simplex chronicus

1.67

0.68

3.6

4.2

—

Paralytic ileus

1.60

0.68

2.3

4.1

—

Injuries involving multiple body regions

1.67

0.68

3.7

4.8

—

Right hemicolectomy

110

1.46

0.68

4.3

3.6

—

Other obstructed labour

1.53

0.68

5.6

4.4

—

Other disorders of nervous system

110

1.46

0.68

3.9

4.2

—

Dislocation, sprain and strain of joints and ligaments of knee

113

914

1.14

0.68

3.7

4.0

—

Fracture of lower leg, including ankle

121

1057

1.13

0.68

3.6

3.9

—

Excessive attrition of teeth

106

928

1.14

0.67

3.6

3.9

—

Malignant melanoma, including Hilmo

302

1.26

0.67

3.1

4.3

—

Appendicitis, broad definition

160

1299

1.11

0.67

3.8

3.9

—

L02BA Anti-estrogens

238

0.71

0.67

3.8

4.1

—

Calculus of lower urinary tract

119

1.43

0.67

2.6

3.6

—

Benign neoplasm of colon, rectum, anus and anal canal

173

1355

1.11

0.66

3.9

3.7

—

Graves ophthalmopathy

1.79

0.66

3.2

4.9

—

Sleep disorders, other/unspecified

1.79

0.66

3.0

5.3

—

Problems related to social environment

1.79

0.66

2.6

5.0

—

Benign leiomyoma with endometriosis

223

1.30

0.66

5.0

4.1

—

Cholesteatoma of middle ear

1.51

0.66

3.2

3.7

—

Early lumbar disc prolapse operation

1.54

0.65

4.8

3.7

—

Benign neoplasm of major salivary glands

171

1.35

0.65

3.1

4.0

—

Unspecified privation

171

1.35

0.65

3.6

3.8

—

Other menopausal disorders

220

1.23

0.65

3.4

4.1

—

Other diseases of gallbladder

1.62

0.65

3.3

4.4

—

Neuralgia and neuritis, unspecified

1.62

0.65

4.1

4.5

—

Dystonia

1.62

0.65

3.6

4.4

—

Ulcerative proctitis

1.62

0.65

3.9

4.1

—

Congenital malformations and deformations of the musculoskeletal system

1.50

0.64

4.1

5.4

—

Special screening examination for infectious and parasitic diseases

166

0.71

0.64

4.9

3.8

—

Other local infections of skin and subcutaneous tissue

163

1.35

0.64

5.3

4.0

—

Pregnancy with abortive outcome

111

508

1.14

0.64

3.4

4.2

—

Hypogonadotropic hypogonadism

1.73

0.64

3.2

4.9

—

Congenital iodine-deficiency syndrome/hypothyroidism

1.73

0.64

3.0

4.5

—

Unspecified dementia

253

0.75

0.63

2.6

3.6

—

Undefined dementia

259

0.75

0.63

2.6

3.6

—

Dementia in Alzheimer disease

416

0.81

0.63

2.9

3.6

—

Abrasion of teeth

580

1.17

0.62

4.5

3.8

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

164

1.34

0.62

4.4

4.2

—

Malignant neoplasm, without specification of site

1.64

0.62

4.3

4.0

—

Other abnormal products of conception

171

0.74

0.62

4.1

4.4

—

Oesophageal obstruction

1.59

0.62

4.2

4.0

—

Spermatocele

173

1.33

0.61

3.6

—

Campylobacter enteritis

1.67

0.61

5.2

4.0

—

Pedestrian injured in collision with pedal cycle

1.67

0.61

5.4

4.7

—

Astigmatism

1.59

0.61

3.8

5.2

—

Other bursal cyst

0.00

0.60

0.0

4.6

—

Congenital malformations of aortic and mitral valves

1.57

0.60

2.6

6.5

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

1.57

0.60

4.1

4.0

—

Triptan medication for migraine, min. 3 purchases

535

1.16

0.60

5.1

4.1

—

Contact with machinery

209

1.29

0.60

2.6

3.5

—

Delivery

323

0.83

0.60

4.2

3.8

—

Medical abortion

105

501

1.14

0.59

3.9

4.2

—

Trigger finger

227

1.28

0.59

3.9

4.2

—

Injuries to the neck

353

1.22

0.59

4.7

3.9

—

Alzheimer’s disease (undefined)

0.00

0.59

0.0

4.7

—

Other other unspecified disorders of the circulatory system

1.54

0.59

6.0

4.3

—

Failed induction of labour

0.00

0.59

0.0

3.7

—

Schizoaffective disorder

1.53

0.59

2.2

4.3

—

Fracture at wrist and hand level

573

1.17

0.59

5.2

3.9

—

Carcinoma in situ of skin of trunk

1.57

0.58

2.9

3.7

—

Impingement syndrome of shoulder

427

1.20

0.58

3.7

4.1

—

Other peripheral vertigo

166

1.33

0.58

5.5

4.3

—

Single spontaneous delivery

323

0.84

0.58

4.3

3.8

—

Benign neoplasm of other and ill-defined parts of digestive system

345

1.22

0.58

3.9

3.8

—

Lichen planus

219

1.28

0.58

4.0

—

Specific development disorders of scholastic skills

0.00

0.58

0.0

7.5

—

Malignant neoplasm of urinary organs

175

1.32

0.58

3.0

4.5

—

Other retinal artery occlusion

1.72

0.57

1.7

4.3

—

Generalized epilepsy

1.72

0.57

3.0

6.4

—

Parkinson's disease, including avohilmo

376

0.80

0.57

2.5

3.9

—

Other arterial embolism and thrombosis

1.48

0.57

6.9

3.6

—

Sub-endpoint used in defining T1D endpoints

521

1.17

0.57

4.8

4.0

—

Postpartum haemorrhage

162

1.30

0.57

4.8

4.1

—

Prepatellar bursitis

1.48

0.57

3.1

4.1

—

Speech and linguistic disorders, excluding more controls

1.48

0.57

5.6

5.0

—

LSIL lesion of the cervix uteri

1.48

0.57

4.6

4.2

—

Inflammatory disease of uterus

132

1.36

0.57

3.2

4.2

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

220

1.27

0.56

2.4

4.2

—

Chondrocostal junction syndrome [Tietze]

1.67

0.56

2.8

5.2

—

Anomalies of dental arch relationship, including avohilmo

190

1.28

0.56

5.7

4.2

—

Hydrocephalus

149

0.67

0.56

2.6

3.8

—

Benign neoplasm of ovary

247

1.26

0.56

3.7

4.2

—

Maternal care for known or suspected abnormality of pelvic organs

125

1.31

0.55

4.2

4.4

—

Disorders of breast

634

1.15

0.55

4.2

4.1

—

Carcinoma in situ, bladder

1.54

0.55

3.3

3.6

—

Other and unspecified disorders of vitreous body

100

875

1.13

0.55

4.4

3.9

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

412

1.19

0.55

4.0

3.9

—

Congenital malformations of genital organs

1.52

0.54

4.2

6.1

—

Other noninfective disorders of lymphatic vessels and lymph nodes

1.58

0.54

3.2

4.1

—

Male infertility

1.58

0.54

8.7

3.3

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

1.58

0.54

5.3

3.7

—

Type1 diabetes, definitions combined, early onset

1.57

0.54

2.3

6.9

—

Extrapyramidal and movement disorders

833

1.13

0.54

3.6

3.7

—

severe traumatic brain injury, does not include concussion

514

0.84

0.54

3.2

3.6

—

Other/unspecified disorders of vestibular function

1.48

0.53

3.8

3.9

—

Other neurotic disorders

1.48

0.53

3.2

4.4

—

Car occupant injured in other and unspecified transport accidents

267

1.24

0.53

3.5

4.0

—

Endometriosis of rectovaginal septum and vagina

1.49

0.53

3.4

4.0

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

1.49

0.53

5.1

4.6

—

Other puerperal infections

1.54

0.53

4.3

4.6

—

Benign neoplasm: Skin of ear and external auricular canal

1.52

0.52

3.7

3.8

—

Biomechanical lesions, not elsewhere classified

1.52

0.52

2.8

4.0

—

Mental disorders, not otherwise specified

1.52

0.52

2.3

4.5

—

Other fall from one level to another

368

1.20

0.52

3.6

4.2

—

Use of galantamine

192

0.73

0.52

3.1

3.8

—

Plantar fascial fibromatosis

146

0.68

0.52

3.4

4.6

—

Follow-up examination after treatment for conditions other than malignant neoplasms

489

1.14

0.52

4.9

3.7

—

Bullous pemphigoid

1.50

0.51

3.5

4.4

—

Overexertion and strenuous or repetitive movements

133

0.68

0.51

3.7

3.9

—

Cystic kidney disease

1.50

0.51

2.0

4.4

—

Car occupant injured in noncollision transport accident

1.50

0.51

2.8

4.6

—

Malignant neoplasm of kidney, except renal pelvis

161

1.31

0.51

3.0

4.4

—

Ptosis of eyelid

203

0.74

0.51

3.7

4.0

—

Retained placenta and membranes, without haemorrhage

136

0.66

0.51

2.3

4.5

—

Cervicalgia

342

1.20

0.51

3.5

4.0

—

Injury of eye and orbit

188

1.28

0.51

3.3

4.2

—

Other specified disorders of external ear

1.39

0.50

2.6

3.8

—

Polyp of the female genital tract

248

1.18

0.50

4.7

4.0

—

Procreative management

354

1.18

0.50

5.2

4.3

—

Acute appendicitis

144

1227

1.10

0.50

4.0

3.9

—

Other, unspecified and serous retinal detachments

1.47

0.50

3.5

4.2

—

Embolic stroke with flimmer

1.46

0.50

3.5

3.6

—

Infections with a predominantly sexual mode of transmission

405

1.17

0.50

3.4

4.2

—

Prolonged pregnancy

1.44

0.49

3.0

3.9

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

101

1.39

0.49

3.6

4.0

—

Diabetic maculopathy, excluding more controls

189

1.27

0.49

6.7

3.7

—

Other complications of labour and delivery, not elsewhere classified

1.57

0.49

3.3

3.4

—

Nontoxic multinodular goitre

344

1.19

0.48

5.5

3.9

—

Focal brain injury

107

0.65

0.48

4.0

3.8

—

Combinations of oral blood glucose lowering drugs

624

1.14

0.48

2.8

3.9

—

Diseases of the myoneural junction and muscle

244

1.23

0.48

2.9

4.0

—

Cerebral palsy and other paralytic syndromes

172

1.28

0.48

2.5

4.6

—

Focal epilepsy, strict definition

376

0.82

0.47

5.1

4.1

—

Malignant neoplasm of colon

272

1.21

0.47

4.1

4.4

—

Sequelae of injuries, of poisoning and of other consequences of external causes

392

1.17

0.46

3.7

3.8

—

Other and unspecified visual disturbances

155

1.29

0.46

3.2

4.3

—

Alzheimer disease, excluding more controls

270

0.83

0.46

3.2

3.8

—

Benign neoplasm: Skin, unspecified

1.43

0.46

2.6

4.4

—

Other noninflammatory disorders of cervix uteri

1.43

0.46

2.9

4.4

—

Retinal vascular disorders

264

1.21

0.45

3.5

3.6

—

Inflammatory disease of cervix uteri

1.43

0.45

3.0

4.6

—

Benign neoplasm: Rectum, anus and anal canal

449

1.16

0.45

3.6

3.8

—

Acute alcohol intoxication ICD-9

1.40

0.45

2.6

4.2

—

Benign neoplasm: Colon, unspecified

581

1.14

0.44

4.0

3.7

—

Nonspecific lymphadenitis

1.37

0.44

4.6

4.7

—

Excessive vomiting in pregnancy

1.37

0.44

3.9

4.8

—

Ganglion

302

1.19

0.44

2.9

4.1

—

Stenosis and insufficiency of lacrimal passages

139

1.30

0.43

3.8

4.5

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

231

1.22

0.43

2.7

4.4

—

Small cell lung cancer

1.62

0.43

1.8

4.0

—

Small cell lung cancer, including Hilmo

1.62

0.43

1.8

4.0

—

Speech and linguistic disorders

1.45

0.43

5.6

5.7

—

Dementia in other diseases classified elsewhere

0.64

0.42

4.2

3.4

—

Other and unspecified disease of Bartholin gland

1.57

0.42

2.6

5.1

—

Other and unspecified mononeuropathies of upper limb

1.56

0.42

2.4

3.7

—

Anisometropia and aniseikonia

1.56

0.42

4.0

4.6

—

Viral conjunctivitis

1.56

0.42

4.8

6.9

—

Abnormal blood-pressure reading, without diagnosis

1.56

0.42

3.0

3.9

—

Left ventricular outflow tract obstruction, narrow definition

1.40

0.42

2.6

6.2

—

Autoimmune hyperthyroidism

1.40

0.42

3.1

4.4

—

Normal-pressure hydrocephalus

0.63

0.42

2.5

3.8

—

Subarachnoid haemorrhage

195

0.77

0.41

2.9

4.4

—

Malignant neoplasm of other and unspecified female genital organs

0.00

0.41

0.0

4.4

—

Evidence of alcohol involvement determined by blood alcohol level

0.00

0.41

0.0

5.7

—

LSIL lesion of the vagina

0.00

0.41

0.0

6.3

—

Other infestations

0.00

0.41

0.0

5.6

—

Type 1 diabetes, definitions combined

1.43

0.41

3.3

3.8

—

Carbimazole or st.post thyroidectomy, condition for graves disease

314

1.18

0.41

3.2

4.0

—

Pregnancy examination and test

0.67

0.41

2.3

4.8

—

Other infective otitis externa

1.39

0.40

3.1

4.0

—

Divergent concomitant strabismus

1.39

0.40

2.5

4.1

—

Otalgia

1.39

0.40

2.7

5.0

—

Disorders of globe

1.47

0.40

2.0

5.0

—

Other disorders of iris and ciliary body

1.47

0.40

2.6

4.6

—

Nontoxic diffuse goitre

1.47

0.40

3.8

4.5

—

Pedal cyclist injured in collision with motor vehicle

1.47

0.40

2.4

6.2

—

Sacroiliitis, not elsewhere classified

1.47

0.40

3.6

5.9

—

Inguinal or femoral hernia, bilateral

250

1.20

0.40

4.1

3.5

—

Peroneal tendinitis

0.00

0.40

0.0

3.1

—

Benign neoplasm: Caecum

227

0.79

0.40

3.6

4.2

—

Contact with lifting and transmission devices, not elsewhere classified

0.00

0.40

0.0

4.2

—

Autoimmune thyroiditis

0.00

0.40

0.0

4.5

—

Maternal care for other conditions predominantly related to pregnancy

147

1.27

0.40

5.9

4.0

—

Fall on and from stairs and steps

474

1.14

0.39

4.3

3.9

—

Alzheimer’s disease (undefined), excluding more controls

0.00

0.39

0.0

5.0

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

207

1.22

0.39

2.7

4.5

—

Hordeolum and other deep inflammation of eyelid

1.31

0.39

3.3

3.8

—

Open wound of abdomen, lower back and pelvis

1.43

0.39

5.2

5.3

—

Amblyopia ex anopsia

1.43

0.39

4.0

7.4

—

Nontoxic goitre/thyroid nodule

531

1.13

0.39

4.7

3.7

—

Lesion of lateral popliteal nerve

1.41

0.39

4.2

3.8

—

Retinal vascular occlusion

260

1.19

0.39

3.5

3.6

—

Other noninflammatory disorders of vagina

1.41

0.39

4.2

3.9

—

Myocardial infarction, with ST-elevation

437

1.14

0.39

3.8

3.6

—

Hypotension due to drugs

0.00

0.39

0.0

5.5

—

Traumatic subdural haemorrhage

285

1.18

0.39

3.4

3.8

—

Benign neoplasm: salivary glands, exclude unknown (D119)

142

1.27

0.38

3.0

4.0

—

Examination and encounter for administrative purposes

1.38

0.38

3.5

3.3

—

Hyperaldosteronism

1.39

0.38

2.2

4.7

—

Cystic kidney disease

1.39

0.38

2.2

4.5

—

Acute appendicitis, no complications

104

947

1.09

0.38

4.2

3.9

—

Vitamin B12 deficiency anaemia

206

1.21

0.37

4.6

3.4

—

Ectopic pregnancy

206

1.21

0.37

2.8

4.9

—

Eating disorders

1.32

0.37

3.8

4.5

—

Endometriosis

256

1.15

0.37

4.0

4.1

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

524

1.13

0.37

3.2

4.0

—

Other and unspecified injuries of shoulder and upper arm

1.35

0.37

2.6

5.9

—

Female infertility, associated with anovulation

1.35

0.37

4.0

2.9

—

Anorexia (incl.atypical)

1.35

0.37

4.6

4.8

—

Other specified/unspecified hearing loss

152

1.25

0.37

3.7

4.2

—

Pre-eclampsia or poor fetal growth

298

1.17

0.36

3.6

4.4

—

Type 1 diabetes, strict (exclude DM2)

1.39

0.36

3.3

5.2

—

Endometriosis diagnosis and infertility diagnosis occurring together

1.36

0.36

4.2

—

Femoral hernia

1.27

0.36

4.8

3.7

—

Desensitization to allergens

1.43

0.35

4.2

6.7

—

1.43

0.35

3.2

3.5

—

Vascular dementia (undefined)

1.31

0.35

2.7

3.7

—

Endometriosis ASRM stages 3,4

288

0.83

0.35

3.3

4.0

—

Focal epilepsy

395

0.86

0.35

4.9

4.0

—

Other deformities of toe(s)

1.40

0.35

7.3

4.5

—

Use of levodopa decarboxylase inhibitor

330

0.85

0.34

2.8

3.5

—

Unspecified abortion

1.36

0.34

2.8

4.9

—

Speech disturbances, not elsewhere classified

172

1.22

0.34

3.5

3.8

—

Pterygium

1.34

0.33

3.5

4.2

—

Fall on and from ladder

145

1.24

0.33

3.1

3.8

—

Flat foot [pes planus] (acquired)

118

1.27

0.33

4.6

4.3

—

Complications of labour and delivery

457

1.10

0.33

4.0

4.2

—

Rheumatic fever incl heart disease

1.31

0.33

3.3

4.5

—

Other obstetric conditions, not elsewhere classified

115

1.22

0.33

5.4

3.8

—

Maternal care for other known or suspected fetal problems

1.27

0.32

4.1

4.0

—

Glucosamine medication

112

964

0.93

0.32

3.5

3.8

—

Hallux valgus (acquired)

435

1.11

0.32

5.0

4.1

—

Abnormal serum enzyme levels

730

0.91

0.32

4.7

3.7

—

L02BX Other hormone antagonists and related agents

132

0.76

0.32

2.8

3.1

—

Malignant neoplasm of breast, ER-positive, including Hilmo

379

1.12

0.32

3.7

4.1

—

Benign neoplasm: Sigmoid colon

412

0.87

0.31

3.4

3.8

—

Inguinal hernia, bilateral

248

1.17

0.31

4.0

3.5

—

Thiazolidinediones

239

1.17

0.31

3.0

3.9

—

Crohn disease (strict definition, all UC cases excluded)

1.35

0.31

3.7

4.9

—

Alzheimer’s disease (Atypical or mixed)

260

0.84

0.31

3.5

3.6

—

Diplopia

230

1.17

0.31

4.1

4.2

—

False labour

131

1.19

0.30

3.6

4.3

—

Injury of muscle and tendon at lower leg level

258

1.16

0.30

4.1

3.7

—

Benign neoplasm: Parotid gland

129

1.24

0.30

2.4

3.7

—

Malignant neoplasm of corpus uteri, including Hilmo

129

1.24

0.30

2.9

4.6

—

Benign neoplasm: Skin of eyelid, including canthus

297

1.15

0.29

3.2

3.9

—

Embolic stroke

108

0.74

0.29

3.1

3.7

—

Clear cell adenocarcinoma of kidney

1.23

0.29

2.7

4.5

—

malignant neoplasm of female genital organs

221

1.17

0.29

3.3

4.1

—

Other and unspecified myopathies

176

1.19

0.28

2.9

3.9

—

Melanoma in situ

1.32

0.28

3.4

4.1

—

Dissection of aorta

1.29

0.28

2.8

3.5

—

Malignant neoplasm of ovary

1.29

0.28

3.4

5.8

—

All dysplastic lesions of the cervix uteri

212

1.17

0.28

4.1

4.4

—

Struck by thrown, projected or falling objec

1.23

0.27

2.5

4.9

—

Other disorders of breast

150

0.80

0.27

4.0

4.3

—

Nontraumatic intracranial haemmorrhage

458

0.89

0.26

3.0

3.9

—

Graves disease, strict definition

104

1.25

0.26

2.9

4.6

—

Postmenopausal bleeding

228

0.89

0.25

3.3

4.1

—

Pedal cyclist injured in transport accident

348

1.12

0.25

3.8

4.1

—

Bicipital tendinitis

1.25

0.25

3.0

4.9

—

Benign neoplasm of urinary organs

1.23

0.25

2.4

3.9

—

Pre-eclampsia

216

1.16

0.25

3.6

4.3

—

Impacted teeth

101

1.23

0.25

3.9

4.6

—

Malignant neoplasm of rectum, including Hilmo

224

0.85

0.25

3.1

4.5

—

Osteomyelitis

105

1.24

0.24

2.9

4.3

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

311

1.13

0.24

3.8

4.2

—

Colon adenocarcinoma

217

1.15

0.24

3.9

4.6

—

Pregnancy, childbirth and the puerperium

233

0.90

0.24

5.1

3.6

—

Colorectal cancer

464

1.10

0.24

3.7

4.0

—

Exposure to other specified factors

150

1308

1.05

0.23

3.7

3.9

—

Otosclerosis

115

1.22

0.23

2.7

4.3

—

Conductive hearing loss, unspecified

115

1.22

0.23

7.1

4.3

—

Single delivery by forceps and vacuum extractor

0.74

0.23

3.3

4.0

—

Dysplasia of cervi uteri

171

1.14

0.23

4.0

—

Vitreous haemorrhage

190

1.16

0.23

3.2

3.8

—

Premature rupture of membranes

102

1.19

0.23

3.9

4.3

—

Secondary parkinsonism, excluding more controls

1.28

0.23

2.6

4.2

—

Complications following abortion and ectopic and molar pregnancy

1.28

0.23

4.4

5.4

—

Pathological resorption of teeth

1.28

0.23

2.8

4.6

—

Acne vulgaris

1.28

0.23

3.0

7.1

—

Other disorders of eyelid

110

988

1.06

0.22

3.2

3.7

—

Secondary parkinsonism

1.25

0.22

2.6

4.5

—

Secondary parkinsonism+Parkinsonism in other disease

1.25

0.22

2.6

4.4

—

Panniculitis affecting regions of neck and back

1.25

0.22

4.2

3.3

—

Medial epicondylitis

1.25

0.22

6.4

5.5

—

Malignant neoplasm of colon, including Hilmo

371

1.10

0.22

4.0

4.2

—

Toxic effect of ethanol

1.22

0.22

2.2

5.2

—

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

144

1.18

0.22

3.7

4.2

—

Follow-up examination after treatment for malignant neoplasms

191

1.15

0.21

3.0

4.0

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1.22

0.21

16.0

4.2

—

Fracture of neck

107

1.22

0.21

3.5

3.8

—

Congenital malformations of great arteries

0.00

0.21

0.0

15.9

—

Tetraplegia

0.00

0.21

0.0

7.2

—

Obsessive-compulsive disorder

1.19

0.21

2.8

5.3

—

Supervision of high-risk pregnancy

101

0.83

0.21

3.4

4.8

—

Sequelae of poliomyelitis

0.00

0.21

0.0

7.1

—

Postprocedural disorders of ear and mastoid process, not elsewhere classified

0.00

0.21

0.0

6.2

—

Hyperkinetic disorders (excl. ADHD)

0.00

0.21

0.0

7.0

—

Crystalline deposits in vitreous body

0.00

0.21

0.0

7.2

—

Complications following myocardial infarction

0.00

0.21

0.0

3.5

—

Other and unspecified mental retardation

0.00

0.21

0.0

15.7

—

Migraine with aura, drug-induced

0.00

0.21

0.0

7.1

—

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

0.00

0.21

0.0

7.6

—

Congenital musculoskeletal deformities of head, face, spine and chest

0.00

0.21

0.0

16.1

—

Other disorders of binocular vision

0.00

0.21

0.0

6.9

—

Disorders in reading

0.00

0.21

0.0

13.8

—

Peptic ulcer

0.00

0.21

0.0

6.3

—

Other and unspecified injuries of abdomen, lower back and pelvis

0.00

0.21

0.0

6.6

—

Malignant neoplasm of cervix uteri

0.00

0.21

0.0

5.3

—

Use of glatiramer acetate

0.00

0.21

0.0

5.1

—

Brain glioblastoma and astrocytoma

0.00

0.21

0.0

4.9

—

Torticollis

0.00

0.21

0.0

4.8

—

Anxious personality disorder

0.00

0.21

0.0

4.7

—

Congenital malformations of uterus and cervix

0.00

0.21

0.0

5.6

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

102

0.78

0.21

4.3

4.8

—

Disorder of lipoprotein metabolism, unspecified

277

1.12

0.21

3.0

4.1

—

Small cell lung cancer, helper endpoint

1.16

0.21

1.8

4.3

—

Melanocytic naevi of lower limb, including hip

1.16

0.21

5.0

4.4

—

Benign neoplasm: Stomach

177

0.85

0.21

2.9

4.3

—

Other abnormal auditory perceptions

0.00

0.21

0.0

5.5

—

Pedestrian injured in other and unspecified transport accidents

0.00

0.21

0.0

6.0

—

Open wound of thorax

0.00

0.21

0.0

5.9

—

Lesion of plantar nerve

1.24

0.21

2.8

4.8

—

Diabetes mellitus in pregnancy

141

0.86

0.21

6.5

4.2

—

Sequelae of poliomyelitis

0.00

0.20

0.0

6.1

—

Lagophthalmos

0.00

0.20

0.0

6.2

—

Disturbances of smell and taste

1.25

0.20

2.8

4.3

—

Insulin, fast-acting (human)

183

1.15

0.20

8.0

3.7

—

Convergent concomitant strabismus

1.23

0.20

5.2

6.0

—

Mandibular retrognathia

1.22

0.20

9.3

6.7

—

Benign neoplasm: Kidney

1.20

0.19

2.8

4.1

—

Other and unspecified iridocyclitis

1.20

0.19

2.2

4.6

—

Single delivery by caesarean section

0.82

0.19

4.8

3.7

—

Impacted cerumen

197

0.86

0.19

6.7

3.7

—

Obesity, other/unspecified

501

1.08

0.19

3.5

4.1

—

Puerperal sepsis

175

0.86

0.18

3.8

4.4

—

Alcohol-induced acute pancreatitis

1.13

0.18

2.5

4.6

—

Gestational diabetes (for exclusion)

188

0.89

0.18

5.8

3.9

—

Thyrotoxicosis

415

0.92

0.18

3.4

4.0

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

111

1.14

0.17

5.7

3.7

—

Melanocytic naevi

507

0.93

0.17

4.7

3.8

—

Ectropion of eyelid

1.21

0.17

2.7

3.7

—

Oral lichen planus, including avohilmo , including avohilmo

1.22

0.17

2.3

5.0

—

Other intracranial haemorrhages

1.11

0.17

2.4

3.8

—

Personal history of malignant neoplasm

0.75

0.17

2.2

5.3

—

Benign neoplasm: Small intestine

0.73

0.17

3.0

3.9

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

186

1.13

0.17

3.0

4.8

—

Burns and corrosions of external body surface, specified by site

148

1.15

0.16

6.8

4.4

—

Noninflammatory disorders of female genital tract

262

1.07

0.16

4.7

4.0

—

Hypoglycaemia, other or unspecified

101

1.19

0.16

4.0

4.1

—

Cerebral cysts

1.16

0.16

2.3

4.2

—

Epilepsy

513

1.07

0.16

4.2

3.8

—

Unspecified urinary incontinence

139

1.15

0.16

3.1

4.8

—

Achilles tendinitis

158

1.14

0.16

3.8

4.0

—

Vascular dementia

226

1.11

0.16

2.8

3.6

—

Infections of genitourinary tract in pregnancy

1.20

0.16

2.5

5.0

—

Other inflammatory liver diseases

1.20

0.16

2.8

4.2

—

Residual foreign body in soft tissue

1.11

0.16

2.7

4.2

—

Other disorders of amniotic fluid and membranes

0.77

0.15

3.0

3.8

—

Use of selegiline

0.76

0.15

2.8

3.8

—

Amputation

224

0.89

0.15

3.3

3.7

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

1.15

0.15

4.7

4.0

—

Endometriosis of ovary

188

0.88

0.15

3.2

4.1

—

Disorders of psychological development

1.14

0.15

5.1

5.4

—

Tooth eruption problems

1.20

0.15

4.8

5.1

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Mycobacterium tuberculosis genotype [Identifier] in Isolate

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS